Document:

EX-10.16

 Exhibit 10.16 

AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE 

ON 
 TRIEX MODULE
TECHNOLOGY 
 This AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON TRIEX MODULE TECHNOLOGY (this “Agreement”)
is effective as of September 2, 2014 (the “Effective Date”) and is by and between THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (“FOUNDATION”), a non-profit educational corporation existing under the laws of
the State of New York, having an office located at 257 Fuller Road, Albany, New York 12203, on behalf of the College of Nanoscale Science and Engineering (“CNSE”) of the State University of New York (the “SUNY”), and SILEVO, INC.
(“SILEVO”), a Delaware corporation with its principal office located at 45655 Northport Loop East, Fremont, California 94555. FOUNDATION and SILEVO are each referred to herein sometimes individually as a “Party” or, collectively,
as “Parties.” 
  

	I.	RECITALS 

 I.1. New York State (“NYS”) under the leadership of Governor Andrew Cuomo has led
the U.S. in multi-billion dollar strategic investments in high technology programs that cover the entire spectrum of clean energy, medical, smart grid and nanotechnology industry needs, from long-term innovative research and development, to workforce development and education, to product prototyping and supporting the transition to scale-up manufacturing and commercialization. 

I.2. New York State’s comprehensive job creation and economic growth agenda for New York provides strategic investments for job creation in emerging high-tech industries across New York State and fosters critical partnerships between State government, the private sector and New York’s top-flight universities and
research institutions. This agenda is embodied by the commitment and growth of CNSE, CNSE’s Smart Systems Technology Commercialization Center (“STC”) located in Canandaigua, New York, CNSE’s partnership with the State University
of New York Institute of Technology (“SUNYIT”) in Utica, New York and other public-private partnerships CNSE operates throughout the State together with their public and private university and industry partners. 

I.3. New York State Governor Andrew Cuomo has identified economic growth in New York State as a leading focus for New York State government seeking to invest
significant levels of financial support for public-private partnerships throughout the Erie-Mohawk Corridor with an emphasis on the Western New York region by constructing, renovating, retrofitting, or rehabilitating state-of-the art facilities with
cleanrooms, clean production space and laboratories supporting manufacturing scale-up operations that would also leverage CNSE’s capabilities, partners, suppliers, and customers. Under a cross-regional partnership, CNSE will seek to develop and
integrate physical and intellectual capabilities to support the transition of technologies into manufacturing scale-up by: 1) leveraging and expanding on unmatched nanoelectronics and photovoltaic research, development, pilot-prototype and
manufacturing capabilities located at CNSE, STC SUNYIT and across Upstate New York; and 2) constructing or renovating a facility located in Western New York that would be operated by SILEVO in support of industrial use and expansion. 

I.4. SILEVO is a leading photovoltaic (“PV”) cell and module technology company that has developed an innovative hybrid solar technology that
combines the best elements of traditional crystalline silicon (cSi), thin film PV and semiconductors to achieve cost-effective high performance solar modules, called TriexTM. 

  

 I.5. SILEVO is seeking to locate a significant expansion of its operations in New York State to establish a
1 million square foot manufacturing facility to produce 1 Gigawatt (“GW”) worth of its Triex module technology with the potential of a Phase II adding an additional 5 GWs of capacity. SILEVO desires collaboration with CNSE combining
SILEVO’s expertise in the new hybrid PV technology with CNSE’s world-class nanoelectronics and PV research, development and deployment (“RD&D”) infrastructure, know-how and industry partnerships to make the expansion
successful and sustainable in the U.S. 
 I.6. SILEVO acknowledges that CNSE is a critical enabling component in maintaining and bolstering the State of New
York’s position as a leader in nanoelectronics, and clean energy technology and recognize the mutual benefit that can be attained by: (i) collaborating with CNSE to bring to the State of New York new research, development, education, and
business investments from the various sectors of the nanoelectronics and PV industry; (ii) fostering critical partnerships among the Parties and the public and private sectors; (iii) transitioning emerging technologies critical for clean
energy and economic competitiveness; and (iv) commercializing emerging clean energy and other nanotechnologies in commercial and consumer applications. 

I.7. SILEVO acknowledges that CNSE has leveraged the experience obtained from its success in nanoelectronics and has expanded further into the areas of clean
energy as evidenced by the establishment of and involvement with CNSE’s Energy and Environmental Technology Applications Center (“E2TAC”), the Department of Energy funded U.S. Photovoltaic Manufacturing Consortium, Inc.
(“PVMC”) headquartered at CNSE, Incubators for Collaborating & Leveraging Energy And Nanotechnology (“iCLEAN”), NREL Clean Energy Alliance, New Energy NY, Nanotechnology Innovations for Clean Energy – Innovative
Partnerships” (“NICE-IP”), and Collaboration for Leveraging Energy And Nanotechnology (“CLEAN”), among others. 
 I.8. CNSE
recognizes SILEVO as a technically competitive, leading researcher, developer and manufacturer of hybrid PV modules with the potential to be the leading seller of PV products in the United States with innovative technology solutions for advanced
energy generation systems used in commercial and consumer applications. 
 I.9. CNSE recognizes SILEVO’s Triex PV module technology is of critical
importance to the United States economic competitiveness and energy independence, among other public policy objectives by providing dramatic improvement in cost and performance. The new Triex PV modules have significantly higher efficiency than
traditional PV available in the market today with the potential to substantially increase efficiency further in the near term. SILEVO’s new Triex PV technology is competitive with other technologies based on the innovative combination of
traditional cSi, thin film PV and semiconductor layers resulting in a higher efficiency cost effective product. SILEVO has already demonstrated the manufacturability of the Triex product at their Chinese facility and want to ramp up production in
the U.S. 
 I.10. The Parties recognize CNSE and its innovative technology transitioning, business development and economic outreach model supporting the
entire R&D – Manufacturing eco-system of companies and research partners as of critical importance to the State and nation’s security and economic competitiveness. 

  
 2 

 I.11. The Parties recognize that New York State Governor Andrew Cuomo has challenged the citizens of Western New
York to over a five (5) year period establish an infrastructure in Western New York that will include developing a comprehensive job creation and economic growth agenda for New York to provide strategic investments for job creation in emerging high-tech industries across New York State and foster critical partnerships between State government, the private sector and New York’s top-flight universities and
research institutions establishing specialized facilities to establish and operate cross-regional, state-of-the-art, R&D, pilot-prototyping, manufacturing scale-up, commercialization and workforce training nexus in Upstate New York. 

I.12. The Parties recognize the Western and Upstate New York region’s premier business leadership and economic development organization and acknowledge
as an imperative for successful transition of the region to a knowledge-based economy the establishment of research centers and product development centers supported by New York’s colleges and universities that will assist in the development of
a stream of innovative products and services by enabling the fabrication and test of prototypes for the region’s existing and emerging clusters. 

I.13. The Parties entered into that certain Agreement for Research & Development Alliance on Triex Module Technology (“Original
Agreement”), effective as of February 24, 2014, and the Parties now wish to amend and restate the Original Agreement as set forth in this Agreement. 

THEREFORE, in consideration of the mutual promises and covenants contained in this Agreement and other good and valuable consideration, the receipt and
sufficiency of which hereby are acknowledged, and intending to be legally bound hereby, the Parties agree as follows: 
  

	II.	DEFINED TERMS 

 In addition to the terms defined elsewhere in this Agreement, the
following terms have the described meanings listed below. 
  

	2.1	Affiliate 

 Affiliate means an entity that Controls, is Controlled by, or is under common
Control with, another entity, but only during the period that such control exists. For purposes of this Agreement, FOUNDATION’s Affiliates shall be deemed to include Fort Schuyler Management Corporation (“FSMC”), CNSE, SUNY IT, the
State of New York and SUNY. SILEVO’s obligations hereunder may be met by SILEVO’s Affiliates. 
  

	2.2	Intentionally deleted. 

  

	2.3	CNSE Facilities 

 CNSE Facilities means the Manufacturing Facility and all other
FOUNDATION, CNSE, and SUNY IT facilities used in the Program (as defined in Exhibit D). 
  

	2.4	CNSE Tools 

 CNSE Tools means the Manufacturing Equipment and all other FOUNDATION and
CNSE tools and equipment used by a Party in the Program. 

  
 3 

	2.5	Control 

 Control means the power to direct the affairs of any individual, corporation,
partnership, joint venture, trust, business association, governmental entity or other entity by reason of ownership of voting stock, by asset acquisition, by contract or otherwise. 

 

	2.6	Knowledge 

 Knowledge means, for SILEVO, the actual knowledge of the officers and
directors of SILEVO and, for FOUNDATION, the actual knowledge of the Principal Investigator. 
  

	2.7	Manufacturing Facility 

 Manufacturing Facility means the approximately 1,000,000 square
feet for manufacturing plant and for administration and business offices and related infrastructure to be located in Buffalo, New York at the Riverbend Development Site consisting of approximately 88.24 acres in the location legally described in
Exhibit H-1 and shown on the site plan attached hereto as Exhibit H-2 (the “Site”). The Site will have on-site parking to accommodate up to 1,460 employees (not less than 500 parking spaces) and sufficient clearances to allow for
logistical flow of incoming and outbound material and legal access on public roads. The Parties will in good faith identify such other terms pertaining to the construction and fit-up and/or retrofit and operation and maintenance of the Manufacturing
Facility, and the Parties shall mutually agree on such terms after the signing of this Agreement by an amendment to this Agreement and/or such other related lease/use agreement as may be desirable. 

 

	2.8	Manufacturing Equipment 

 Manufacturing Equipment means the equipment generally described
in Exhibit C of this Agreement, which includes manufacturing tools, including PV module processing and metrology equipment that are necessary to perform the Manufacturing Operations, in accordance with SILEVO’s specifications and as agreed to
by FOUNDATION. The Parties will jointly establish a working group to identify and agree on the specifications and other requirements for the Manufacturing Equipment that will be purchased by FOUNDATION as provided in Section 4.1(c). 

 

	2.9	Manufacturing Operations  

 Manufacturing Operations means the SILEVO and/or its
Affiliates activities in connection with the manufacture of Triex and/or any other products and all other activities related thereto in the Manufacturing Facility, including without limitation such costs required to achieve Full Production Output as
defined in Section 4.1(b). 
  

	2.10	Program 

 Program means the various activities undertaken or conducted by or on behalf of
the Parties throughout the Term of and pursuant to the terms and conditions of this Agreement. 

  
 4 

	III.	OBJECTIVES 

  

	3.1	Manufacturing, Business Outreach, and Economic Development 

 The Parties are entering
into this Agreement for the purpose of creating a research and development (R&D) collaboration and economic arrangement on the terms set forth herein for the location of SILEVO R&D resources at CNSE and manufacturing and business operations,
including a 1 GW manufacturing plant, in Western New York. 
  

	3.2	Program “Essential Purposes” 

 For purposes of this Agreement, the
“Essential Purposes” of the Program shall be as follows: 
  

	 	(a)	Establish a mutually beneficial joint effort focused on the U.S. based manufacturing expansion and commercialization of SILEVO’s innovative hybrid solar module technology, Triex, and the research and development
necessary to achieve SILEVO’s next generation technology improving on the Triex product; and 

  

	 	(b)	Establishment of SILEVO manufacturing, business, and related operations in Western New York at the Site in accordance with Sections IV and V. 

 

	IV.	SILEVO PROGRAM CONTRIBUTION OBLIGATIONS 

  

	4.1	Manufacturing Operations and Equipment 

  

	 	(a)	SILEVO agrees, after Manufacturing Facility Completion, to: (i) establish a next generation Triex technology Manufacturing Operation in Western New York at the Manufacturing Facility; (ii) jointly commission,
with FOUNDATION, the Manufacturing Operation as soon as commercially reasonable, and (iii) achieve Full Production Output as soon as commercially reasonable. SILEVO further agrees in connection with the Manufacturing Operation, after
Manufacturing Facility Completion, to achieve the levels of investments over the Term (as defined below) and the creation and retention of high tech jobs during the Term as outlined below and in accordance with the table attached and made an
integral part of this Agreement as Exhibit A. 

  

	 	(b)	As used in this Agreement, the following terms have the following meanings: 

“Manufacturing Facility Completion” means that the Manufacturing Facility and all related infrastructure have been completed in
accordance with the agreed-on plans, specifications and requirements, all utilities serving the Manufacturing Facility are fully operational, a certificate of occupancy or its equivalent for the entire Manufacturing Facility has been issued by the
applicable governmental agency and all Manufacturing Equipment has been acquired and delivered to the Manufacturing Facility. 

“Manufacturing Equipment Commissioning” means that after Manufacturing Facility Completion has been achieved, all Manufacturing
Equipment has been installed in the Manufacturing Facility, has been commissioned, and the entire manufacturing line and related Manufacturing Equipment is fully operational. 

  
 5 

 “Full Production Output” means that Manufacturing Operations are being conducted at
substantially full capacity across the entire manufacturing line in the Manufacturing Facility. 
  

	 	(c)	FOUNDATION is responsible at its cost (subject to the limits below in Sections 5.1(a) and 5.1(c)) to achieve Manufacturing Facility Completion, including to acquire all Manufacturing Equipment and to provide for all
Manufacturing Equipment to be delivered to the Manufacturing Facility. Once Manufacturing Facility Completion has been achieved, including all Manufacturing Equipment has been acquired and delivered to the Manufacturing Facility, SILEVO is
responsible at its cost to achieve Manufacturing Equipment Commissioning and Full Production Output; provided, however, the cost of the Manufacturing Equipment Commissioning shall be funded by FOUNDATION, subject to Section 5.1(c). FOUNDATION
shall exercise its best commercially reasonable efforts to achieve Manufacturing Facility Completion within twelve (12) months after the Effective Date but under all circumstances shall achieve Manufacturing Facility Completion within eighteen
(18) months after the Effective Date. SILEVO shall exercise its best commercially reasonable efforts to achieve (i) Manufacturing Equipment Commissioning within three (3) months after Manufacturing Facility Completion, and
(ii) Full Production Output within three (3) months but not more than six (6) months after Manufacturing Equipment Commissioning. 

  

	 	(d)	As used herein, the “Completion Deadline” shall mean the date that is eighteen (18) months after the Effective Date (without regard to the impact of Force Majeure as provided in Section 19.5).

  

	 	(e)	SILEVO, at its expense, shall be responsible for operating and managing all aspects of the Manufacturing Operations at the Manufacturing Facility following the Manufacturing Facility Completion, including, without
limitation, on-going clean production space and laboratory mechanical, electrical and specialty material handling infrastructure, Triex PV module fabrication equipment and material requirements planning systems, ESH compliance and physical and
security operations, hiring the workforce to perform Manufacturing Operations in accordance with the terms of this Agreement, procuring the raw materials, manufacturing the Triex products, selling and distributing the Triex products, and maintaining
compliance with all applicable laws. Subject to Section VIII, SILEVO shall own any and all of the proprietary technology that its Representatives (as defined in Exhibit D) created during the Term in the performance of the Manufacturing Operations at
the Manufacturing Facility and that is necessary and useful for manufacturing the Triex products. Except for the Manufacturing Facility that will be owned or controlled by or on behalf FOUNDATION and the Manufacturing Equipment that will be owned by
FOUNDATION and made available for Manufacturing Operations, SILEVO will also own all the inventory, product, output, and other property it purchases or creates associated with running the operations of the Manufacturing Operation. The profit or
losses resulting from the Manufacturing Operation shall accrue solely to SILEVO. Subject to Section 4.2, SILEVO shall be responsible for all taxes, including, without limitation, federal and local taxes, associated with the Manufacturing
Operation, subject to any benefits that SILEVO may obtain under the Start-Up NY program as provided in Section 4.8. 

  
 6 

	 	(f)	The Parties will mutually agree upon the list of equipment required for the Project in the manner provided for in this Section 4.1(f) and estimated to total $400 Million. Exhibit C identifies SILEVO’s general
requirements with respect to the Manufacturing Equipment, but the Parties will need to mutually agree on the specifications and other aspects of the final equipment list, as well as the specifications and requirements for the Manufacturing Facility.
As there are different lead times needed to order different components of the Manufacturing Equipment, the process to finalize the specifications of, and to negotiate pricing and issue purchase orders for, the Manufacturing Equipment may occur in
phases. 

 Sixty (60) days prior to each Order Date, SILEVO shall provide FOUNDATION with written notice (the
“Requirements Notice”) of the specifications, requirements, vendors and other key information (collectively, “Requirements”) concerning each component of the Manufacturing Equipment that SILEVO believes is necessary to properly
conduct the Manufacturing Operations. “Order Date” means the date, as determined by SILEVO, that a purchase order must be issued as to a particular component of Manufacturing Equipment in order for that component of Manufacturing Equipment
to be procured, manufactured and/or assembled by the vendor in sufficient time to be delivered to the Manufacturing Facility within twelve (12) months after the Effective Date. 

The parties will establish a joint working group to discuss the Requirements with respect to each component of the Manufacturing Equipment and
to negotiate the pricing of each such component with prospective vendors. The joint working group will reach agreement on the final Requirements and pricing for such component of the Manufacturing Equipment (the “Final Requirements”)
within thirty (30) days after SILEVO has delivered the Requirements Notice with respect to such component of the Manufacturing Equipment to FOUNDATION. Terms will be subject to FOUNDATION final approval and must comply with commercially
reasonable FOUNDATION procurement policies, which will be made available to SILEVO. Notwithstanding the foregoing, SILEVO retains 100% control of equipment vendor and model decisions in order to execute to their performance requirements and
timelines.
 Once the parties have agreed on the Final Requirements and pricing as to a component of the Manufacturing Equipment, FOUNDATION
will issue a purchase order for such component within thirty (30) days thereafter. 
 The Parties currently anticipate that it will cost
as much as $400 Million to acquire, install and commission the Manufacturing Equipment. FOUNDATION will provide up to $400 Million for the Manufacturing Equipment, as provided in Section 5.1(c). The Parties agree that if additional pricing
discounts are able to be obtained by FOUNDATION for the Manufacturing Equipment, subject to SILEVO’s approval, then the $400 Million amount referenced herein and in Section 5.1(c) below, will be reduced by the corresponding discount
negotiated by FOUNDATION. 

  
 7 

	 	(g)	Notwithstanding the foregoing, SILEVO will make reasonable efforts to provide first consideration to New York based suppliers of equipment, materials and other items required for the establishment and growth of its
Manufacturing Operations in order to retain as much manufactured content as is practical within New York State. 

  

	 	(h)	SILEVO agrees to pay FOUNDATION the Manufacturing Equipment Program Payments that become due and payable to FOUNDATION, if any, in accordance with the terms identified in Exhibit G. 

 

	 	(i)	Intentionally deleted. 

  

	4.2	Manufacturing Facility 

 SILEVO agrees to lease from FOUNDATION or FOUNDATION’s
designee the Manufacturing Facility and the Manufacturing Equipment in accordance with the terms set forth in this Agreement, including Exhibit A. After the Manufacturing Facility Completion, SILEVO is responsible for paying for all costs associated
with the operation of the Manufacturing Facility and the property on which the Manufacturing Facility is situated, including without limitation maintenance and operating expenses, utilities, municipal charges, but excluding real estate taxes
assessed against the Manufacturing Facility and the property on which the Manufacturing Facility is situated and any amount(s) paid pursuant to a PILOT Agreement or such other agreement with a governmental entity, including without limitation
payments by contribution, provided, however, that all such costs shall be set forth in and subject to a written lease agreement between FOUNDATION (or, if a designee acquired the Site, such designee) and SILEVO that is consistent with this
Agreement. Notwithstanding the foregoing or anything to the contrary in this Agreement, including Sections 4.1(e), 4.3 and 15.7, with respect to the Manufacturing Facility and the property on which the Manufacturing Facility is situated, under the
written lease agreement between FOUNDATION (or, if a designee acquired the Site, such designee) and SILEVO, SILEVO shall in no event have any obligation to perform or to pay directly, or to reimburse FOUNDATION for, and FOUNDATION shall be solely
responsible for: (a) costs caused by the violation of any law by FOUNDATION or its Affiliates, or their respective agents, employees or contractors; (b) costs caused by condemnation or casualties that are not caused by the negligence or
willful misconduct of SILEVO or its agents, employees or contractors or that are of a type required to be insured against by FOUNDATION under Exhibit F; (c) costs to correct any construction defect in the Manufacturing Facility or to comply
with any covenant, condition, restriction or law applicable to the Manufacturing Facility on the Manufacturing Facility Completion date; (d) insurance costs for coverage that is FOUNDATION’s responsibility hereunder, including premiums,
insurance deductibles, and co-insurance payments; (e) costs of structural or other repairs that are FOUNDATION’s responsibility under Section 15.7; or (f) any fee or compensation to FOUNDATION or its Affiliates, designees, agents
or contractors for management or administration of the Manufacturing Facility. The Parties acknowledge and agree that they are continuing to develop the full scope of terms under which the Parties will conduct this alliance. The Parties acknowledge
and agree that the key terms are contained in this Agreement; however, one or more follow on contracts and/or amendments in addition to this Agreement may be needed to fully detail and complete the Parties’ current and expected subsequent
understandings. Therefore, it is anticipated that this Agreement will be amended and/or supplemented to accommodate the Parties further agreement on terms. 

  
 8 

	4.3	SILEVO Investment & Spending  

 In accordance with and subject to the terms set
forth in this Agreement, including Exhibit A, provided FOUNDATION performs its obligations as required hereunder: (a) SILEVO commits to invest and spend in the Manufacturing Operation at a level that ensures competitive product costs as
determined by the market place for a minimum of five (5) years from Full Production Output from the Manufacturing Operation; (b) SILEVO will be responsible for and pay all costs associated with operation of the Manufacturing Facility
during the Term after the Manufacturing Facility Completion; and (c) SILEVO will spend or incur approximately $5 Billion in combined capital, operational expenses and other costs in New York State (which, for the avoidance of doubt, shall
include amounts spent or incurred by SILEVO for consumables and raw materials consumed or used by SILEVO at the Manufacturing Facility or other manufacturing facility in the State of New York), including at its next generation manufacturing,
business and related operation in Western New York, during the ten (10) year period commencing with Full Production Output. 
  

	4.4	SILEVO Employment Targets 

  

	 	(a)	Provided FOUNDATION performs its obligations under Sections 4.1(c) and 5.1(a) - 5.1(c), SILEVO will employ and hire as SILEVO employees personnel for a minimum of 1,460 high tech jobs for the Manufacturing Operation at
the Manufacturing Facility in Western New York, with SILEVO to employ and hire as SILEVO employees personnel for 900 of such jobs over the initial two (2) years of the collaboration commencing on the Manufacturing Facility Completion Date as
follows (the number of job hires in each job category below represent the job hires that must be in place by the end of the 24th month): 

 

			
	Positions	  	Month 24
	 Operators
	  	710
	 Maintenance
	  	100
	 Facilities
	  	20
	 Manufacturing Engineers
	  	50
	 Procurement
	  	8
	 Administration
	  	12
		
	 Totals:
	  	900

 If Manufacturing Facility Completion occurs after the Completion Deadline, then the periods set forth above
shall be extended one day for each day between the Completion Deadline and the date that Manufacturing Facility Completion occurs. SILEVO commits to the retention of these jobs for a period of no less than five (5) years. The jobs set forth in
this Section 4.4(a) and in Section 4.4(b) below are expected to be high tech and related service and manufacturing jobs and that conform with the requirements of the funding agency(ies) supporting this Agreement. 

 

	 	(b)	In addition to the 1,460 jobs under Section 4.4(a), provided FOUNDATION performs its obligations under Sections 4.1(c) and 5.1(a) - 5.1(c), SILEVO agrees to employ personnel for a minimum of 2,000 jobs over the
five years of the collaboration following Manufacturing Facility Completion to be located in New York State to support downstream solar panel sales and installation activities within New York State. SILEVO commits to the retention of these jobs for
a period of no less than five years. 

  
 9 

	 	(c)	In addition to the 3,460 jobs under Sections 4.4(a) and 4.4(b), provided FOUNDATION performs its obligations under Sections 4.1(c) and 5.1(a) - 5.1(c), SILEVO commits to work with FOUNDATION, on behalf of CNSE, to
attract and retain from SILEVO contractors and suppliers 1,440 support jobs to be located in New York State following the Full Production Output date. 

  

	4.5	SILEVO R&D/Programmatic Commitments  

 SILEVO commits to use its commercially
reasonable efforts to assist, guide and execute the activities outlined below following Manufacturing Facility Completion, provided FOUNDATION performs its obligations under Sections 4.1(c) and 5.1(a) - 5.1(c): 

 

	 	—	 	Work with FOUNDATION, on behalf of CNSE, to develop next generation PV module technology educational curriculum and workforce training content; deliver joint educational programs, seminars, and conferences.

  

	 	—	 	Offer internships that will enable SUNY students to participate in the development and manufacture of next generation PV modules and related devices. 

 

	 	—	 	Participate, as and when appropriate, in the energy related centers CNSE has established or participate in programs such as E2TAC, PVMC, iCLEAN, NREL Clean Energy Alliance, New Energy NY, NICE-IP, and CLEAN.

  

	 	—	 	Provide leadership assistance, pertinent resources, and undertake collaborative R&D activities for the establishment and growth of next generation PV module commercialization in association with PVMC.

  

	 	—	 	Work with FOUNDATION, to develop joint economic outreach proposals targeting federal and State funding programs and implement joint business development strategies. 

 

	4.6	Contribution Verification and Audit 

 SILEVO represents that it has received all
corporate consents and approvals it requires to enter into this Agreement and that it either has received or, within 45 days following the Effective Date, will receive all corporate consents and approvals it requires to perform its obligations under
this Agreement. SILEVO shall give FOUNDATION written notice of its failure to receive all corporate consents and approvals within 45 days following the Effective Date for SILEVO to spend or incur approximately $5 Billion in combined capital,
operational expenses and other costs in New York State under subpart (c) of Section 4.3 of this Agreement within 5 business days after such 45 day period. Following Manufacturing Facility Completion, SILEVO shall provide FOUNDATION with
reports verifying SILEVOs contributions to the Program and the fair market value of such contributions and such other information as reasonably requested by FOUNDATION, with such reports being duly acknowledged by an officer of SILEVO and in such
form as reasonably requested by FOUNDATION. During any audit, FOUNDATION or its accounting firm may examine and copy SILEVO’s books, records, documents, and other supporting data relating to this Agreement and the Program expenditures, provided
that FOUNDATION and its accounting firm comply with reasonable confidentiality requirements. SILEVO shall maintain accurate books, records, documents, and other supporting data which relate to all financial matters concerning the Program and its
obligations under this Agreement for six (6) years from the date of termination of this Agreement. FOUNDATION will notify SILEVO in writing before any audit and will conduct such audit at reasonable times. 

  
 10 

	4.7	PHASE II 

 SILEVO or a SILEVO Affiliate may develop solar panel manufacturing capacity
beyond that described in this Agreement (“Phase II”). (For the avoidance of doubt, Phase II shall not include SILEVO’s contemplated development facility in California that will have ancillary manufacturing.) For Phase II, SILEVO may
occupy additional space at the Riverbend Development Site. The Parties agree to discuss developing a strategy for locating SILEVO’s Phase II in New York State, including the constructing, renovating, retrofitting, or rehabilitating of
additional manufacturing facility space. If located in New York State, the Phase II space is intended by the Parties to be state-of-the-art manufacturing facilities and infrastructure, to be owned by FOUNDATION or its designee, assigned to the
exclusive use of, and operated by SILEVO at the Riverbend Development Site, in support of Phase II of SILEVO’s manufacturing operations. Phase II may support production of up to an additional 5 GWs of SILEVO’s innovative Triex PV modules
and create such additional manufacturing and support jobs as mutually agreed to in writing by the Parties. As sources of capital are not yet identified for this Phase II expansion, whether from collaboration between the Parties, the State, and/or
via SILEVO’s own fundraising efforts, the Parties will identify future commitments if and when appropriate, and such future commitments, if any, will be subject to further written agreement of the Parties. SILEVO hereby grants FOUNDATION on
behalf of CNSE the right to have the first opportunity to discuss, negotiate, and enter into an agreement with SILEVO or a SILEVO Affiliate with respect to the location of Phase II. If, at any time during the Term of this Agreement, SILEVO or a
SILEVO Affiliate has a commercially reasonable good faith intention to proceed with Phase II, then prior to SILEVO or a SILEVO Affiliate entering into a binding agreement with respect to the location, lease or purchase of Phase II with any party
other than FOUNDATION on behalf of CNSE, SILEVO will notify FOUNDATION on behalf of CNSE of the commercially reasonable good faith intention of SILEVO or a SILEVO Affiliate to proceed with Phase II. The Parties will negotiate in good faith and
attempt to reach a mutual agreement in writing within 120 days from the date on which FOUNDATION receives notice from SILEVO (“Negotiation Period”) for SILEVO or a SILEVO Affiliate to locate Phase II in New York State. During the
Negotiation Period, neither SILEVO nor any of its Affiliates may negotiate with any party other than FOUNDATION on behalf of CNSE with respect to Phase II. After expiration of the Negotiation Period, if the Parties have not reached an agreement in
writing for SILEVO or a SILEVO Affiliate to locate Phase II in New York State, then SILEVO will be free to locate Phase II at any location it determines. 
  

	4.8	START-UP NY 

 The Parties will use good faith efforts to pursue with New York State, the
inclusion of the Riverbend Development Site in the Start-Up NY Zone. In the event the SILEVO location in Western New York is designated by New York State as a Start-Up NY zone, SILEVO and FOUNDATION commit to working together to identify additional
SILEVO commitments in jobs and investments at its location in Western New York. 

  
 11 

	V.	FOUNDATION PROGRAM CONTRIBUTION OBLIGATIONS 

  

	5.1	Manufacturing Facility and Manufacturing Equipment  

  

	 	(a)	FOUNDATION will generate funding from the State of New York sufficient to design and construct the Manufacturing Facility, not to exceed $350 Million, to be administered through FOUNDATION, to build the Manufacturing
Facility and related infrastructure, as may be mutually agreed to by the Parties, to house SILEVO’S Manufacturing Operations in Western New York at the Site. The Manufacturing Facility will be constructed and owned and controlled by FOUNDATION
and/or its designee and, in accordance with this Agreement, including Exhibit A, leased to SILEVO for its exclusive use for a minimum of ten (10) years. Under no circumstances will the costs to design and construct the Manufacturing Facility
and related infrastructure exceed $350 Million. 

  

	 	(b)	The Parties agree that SILEVO will have the opportunity to fully participate in the design and construction process for the Manufacturing Facility. FOUNDATION and SILEVO shall jointly negotiate the contracts for the
design and construction of the Manufacturing Facility including approving the budget for the contracts for the design and construction of the Manufacturing Facility, with the intent of the Manufacturing Facility to be completed in compliance with
SILEVO’s requirements under this $350 Million allocation. FOUNDATION shall cause the Manufacturing Facility to be constructed in a good and workmanlike manner in accordance with all laws, plans approved by SILEVO consistent with the
requirements set forth in Exhibit B-1 and a detailed project schedule consistent with Section 4.1(c), pursuant to one or more guaranteed maximum price contracts requiring competitive bids for subcontractors. Notwithstanding anything to the
contrary in Sections 5.1(a), (c), (d) and (h) and Exhibit A, FOUNDATION shall be solely responsible for, and the $350 Million and $750 Million amounts referenced herein shall not be applied toward, costs for roads, utilities and other
site improvements (including those described in Exhibit B-2), which FOUNDATION shall cause to be installed as part of the Manufacturing Facility. 

  

	 	(c)	FOUNDATION will generate funding from the State of New York sufficient to acquire, deliver to the Manufacturing Facility and commission the Manufacturing Equipment, not to exceed $400 Million, to be administered through
FOUNDATION, to advance funds to equip the Manufacturing Facility with the Manufacturing Equipment. The Manufacturing Equipment will be owned by FOUNDATION and, in accordance with this Agreement and Exhibit A, leased to SILEVO for its exclusive use
for a minimum of ten (10) years. Under no circumstances will the FOUNDATION’s obligation to advance funds for the costs associated with the Manufacturing Equipment exceed $400 Million. If SILEVO fails to achieve the Investment and Job
Milestones set forth in Exhibit G, then SILEVO must pay FOUNDATION the Program Payments in accordance with Exhibit G. 

  

	 	(d)	Under no circumstance will FOUNDATION costs for the Manufacturing Facility and Manufacturing Equipment exceed $750 Million. 

  

	 	(e)	FOUNDATION or, if a designee acquired the Site, such designee will lease the Manufacturing Facility to SILEVO for the consideration of $1.00 per year for a minimum of ten (10) years in accordance with the terms of
a separate written lease agreement consistent with the terms of this Agreement and FOUNDATION will lease the Manufacturing Equipment to SILEVO for the consideration of $1.00 per year for a minimum of ten (10) years, which leases shall commence
on the Manufacturing Facility Completion and expire on the expiration of the Term and permit SILEVO access thereto prior to the commencement date. 

  
 12 

	 	(f)	The Parties will enter into such other terms and/or agreements and take such other actions as are reasonably necessary or advisable to give effect to the key terms of this Agreement and implementation of the agreements
of the Parties contained in this Agreement. 

  

	 	(g)	FOUNDATION (or its Affiliate) and SILEVO will mutually agree in writing on terms associated with any option to renew the lease for the Manufacturing Facility and the Manufacturing Equipment from FOUNDATION to either: 1)
allow SILEVO to purchase the Manufacturing Equipment at fair market value and lease or purchase the Manufacturing Facility at fair market value from FOUNDATION; or 2) with SILEVO committing to spend or incur at least $3 Billion in additional
combined capital, operational expenses and other costs in New York State (as described in Section 4.3(c)), including at its next generation manufacturing, business and related operation in Western New York, during a ten (10) year period
commencing on the tenth anniversary of Manufacturing Facility Completion, FOUNDATION (or its Affiliate) will extend the $1.00 per year lease terms for the Manufacturing Facility for an additional ten (10) years, including use of the
Manufacturing Equipment at no additional cost. 

  

	 	(h)	FOUNDATION represents that it has received all FOUNDATION consents and approvals it requires to enter into and perform its obligations under this Agreement (subject to receipt of the funding commitments and permits in
subparts (i) and (ii) below) and agrees that the following events (each, a “Milestone Event”) must occur by the following dates (each, a “Milestone Date”), which it shall use commercially reasonable efforts to achieve:

 (i) FOUNDATION has obtained the award by the State of New York to provide FOUNDATION with $225 Million of the total not to
exceed funding amount of $750 Million required under Sections 4.1(c) and 5.1(a) - 5.1(c). By no later than forty-five (45) days after the Effective Date, FOUNDATION will have obtained the award from the State of New York to provide FOUNDATION
with the balance of the total not to exceed funding amount of $750 Million required under Sections 4.1(c) and 5.1(a) - 5.1(c) for the construction of the Manufacturing Facility and site development and the purchase, installation and commissioning of
the Manufacturing Equipment and for ongoing performance of FOUNDATION’s obligations under this Agreement. FOUNDATION shall give SILEVO written notice of its receipt or failure to receive such funding commitments within 5 days after such
Milestone Date. 
 (ii) FOUNDATION represents that FOUNDATION’s Affiliate, FSMC, has acquired fee simple title to the Site. By no later
than forty-five (45) days after the Effective Date, FOUNDATION or FOUNDATION’s Affiliate will obtain all building permits and all approvals needed to build the Manufacturing Facility in accordance with the plans, specifications and other
requirements agreed on in writing by the Parties and will have commenced or caused to be commenced construction on the Manufacturing Facility and related infrastructure. 

  
 13 

 (iii) By no later than thirty (30) days after the Parties have agreed on the Final
Requirements for each component of the Manufacturing Equipment, FOUNDATION has issued purchase orders for the purchase of such Manufacturing Equipment that complies with the Final Requirements, and the vendors of the Manufacturing Equipment have
accepted such purchase orders. As the purchase of components of the Manufacturing Equipment may occur in phases, each prospective purchase of a component of the Manufacturing Equipment shall create a separate Milestone Event. 

(iv) By the dates set forth on Exhibit I (the “Construction Milestones”), FOUNDATION (or its Affiliate) will have caused its
contractors to achieve the Milestone Events described in Exhibit I. 
  

	 	(i)	If any Milestone Event fails to occur by the applicable Milestone Date, the Parties shall immediately confer to discuss the reasons for the delay and the date that FOUNDATION expects the Milestone Event to occur.
Notwithstanding the foregoing or anything to the contrary contained in this Agreement (including Section 11.2 and Section 19.5, neither of which shall serve to extend any Milestone Date), if a Milestone Event does not occur within thirty
(30) days after the applicable Milestone Date set forth above, then (1) either Party shall have the right to terminate this Agreement at any time thereafter with respect to the failure of a Milestone Event described in clause
(i) above (provided FOUNDATION may only do so if it delivers written notice of such termination to SILEVO within fifteen (15) days after such Milestone Event), and (2) SILEVO shall have the right to terminate this Agreement at any
time thereafter with respect to the failure of a Milestone event described in clauses (ii), (iii) and (iv) above. If a Party elects to exercise its termination rights under this Section 5.1(h), it shall provide written notice of
termination to the other Party, in which case neither Party shall have any liability or obligation to the other Party arising out of any such termination. 

Additionally, once FOUNDATION has commenced construction of the Manufacturing Facility, if it encounters a condition on or about the
Manufacturing Facility Site or circumstances arise such that it can be reasonably anticipated that Manufacturing Facility Completion cannot be achieved within three (3) months after the Completion Deadline, then SILEVO shall have the right to
terminate this Agreement at any time after such delay has been identified by providing written notice to FOUNDATION, in which case neither Party shall have any liability or obligation to the other Party arising out of any such termination. 

FOUNDATION (or its Affiliate) and SILEVO will jointly negotiate the contracts with the developer, construction contractor, and architect for
the development, design and construction of the Manufacturing Facility and such contracts with the contractor, architect and developer will include payment obligations for the failure of the Construction Milestones to be met by the dates set forth
in Exhibit I in such amounts as jointly negotiated by FOUNDATION (or its Affiliate) and SILEVO with the contractor, architect and developer, which payments, if any, FOUNDATION (or its Affiliate) will use for the Manufacturing Facility and Site. 

  
 14 

	5.2	Workforce Education and Training  

 FOUNDATION commits to work with SILEVO to help
recruit, relocate and train the workforce in Western New York necessary to staff SILEVO’s Manufacturing Facility. 
  

	5.3	FOUNDATION R&D Funding Targets  

 FOUNDATION commits to work with SILEVO to identify
sources of funding to develop PV technologies. Such funding is projected to be generated from public and private funding sources. 
  

	5.4	Programmatic and Operational Commitments  

 FOUNDATION shall use best efforts to provide
programmatic, logistical, and financial support and provide on-going economic outreach support leading to the submission of joint proposals for federal and State economic, technology and business development and other grant opportunities to assist
SILEVO in the development and execution of the activities outlined in Section III.2., as mutually agreed upon between FOUNDATION and SILEVO. 

FOUNDATION will use best efforts to make available to SILEVO relationships with already established clean energy centers and incubators such as
E2TAC, PVMC (Halfmoon and Rochester locations), iCLEAN, NREL Clean Energy Alliance, New Energy NY, NICE-IP, and CLEAN to benefit SILEVO’s business endeavors in New York State and across the country. 

FOUNDATION will use best efforts to provide an outlet for SILEVO’s Triex PV modules produced at the Manufacturing Facility through various
pathways including New York State Energy Research and Development Authority (“NYSERDA”), which acts as the central procurement administrator for the New York State Public Service Commission’s New York State Renewable Portfolio
Standard (“RPS”) targeting thirty percent (30%) of the State’s electrical consumption by 2015 to be generated from renewable sources, such as PV solar. 

FOUNDATION will use best efforts to assist SILEVO in negotiating terms with key utilities that impact Manufacturing Facility site running
costs. 
  

	VI.	FOUNDATION PRINCIPAL INVESTIGATOR 

 FOUNDATION shall provide or shall cause to be
provided Dr. Alain E. Kaloyeros as the principal investigator regarding all technical, programmatic and facilities use requirements in respect of the terms and conditions of this Agreement and regarding the supervision, management and
operation of the Program. If Dr. Alain E. Kaloyeros’ affiliation with CNSE should terminate for any reason, an appropriate replacement reasonably acceptable to SILEVO shall be appointed by FOUNDATION. 

 

	VII.	FOUNDATION GUIDELINES 

 FOUNDATION may provide to SILEVO documents setting forth
commercially reasonable guidelines applicable to (a) SILEVO’s employees and agents that are resident or working at the CNSE Facilities and, to the extent applicable, such guidelines shall be consistent with the terms and conditions of this
Agreement, and (b) SILEVO’s use of CNSE Facilities for conducting operations of the Program. The Parties shall agree upon and shall document other guidelines that shall apply to the Parties’ employees and agents participating in the
Program. 

  
 15 

	VIII.	INTELLECTUAL PROPERTY 

 Rights in and obligations with respect to intellectual property
created under this Agreement shall be in accordance with the terms of Exhibit D. Except as set forth in Exhibit D, no rights in any intellectual property are conveyed or granted by or under this Agreement. 

 

	IX.	PROJECTS 

 The Parties may from time to time during the Term of this Agreement mutually
agree to define and enter into one or more Statement(s) of Work (“SOW(s)”) for Projects in accordance with Exhibit D. 
  

	X.	PROGRAM REVIEW AND DISPUTE RESOLUTION 

  

	10.1.	The Parties will establish an annual program review process with appropriate senior executives of the Parties of at least the level of Vice President or other comparable level as defined by each Party.

  

	10.2.	Each Party shall designate a “Program Manager” to oversee its participation in Projects and the Program. 

  

	10.3	The Program Managers will exercise reasonable efforts in attempting to reach mutual agreement on all issues and matters under their consideration. If the Program Managers cannot reach agreement in a reasonable amount of
time, the Program Managers shall refer the dispute in writing to the senior executives of the Parties that are designated under Section 10.1, who shall discuss and meet in person, if necessary, in order to negotiate a resolution to the dispute.

  

	XI.	TERM AND TERMINATION 

  

	11.1	Term  

 The term of this Agreement begins on the Effective Date and shall extend for ten
(10) years from when Manufacturing Facility Completion has been achieved, unless the Parties extend the term of this Agreement in accordance with the terms of this Agreement or unless this Agreement is terminated by a Party in accordance with
the terms of this Agreement (“Term”). The Parties may mutually agree in a written amendment to this Agreement to extend the Term of this Agreement for an additional ten (10) years or for such other period of time as the Parties agree.
The Parties anticipate the need for SILEVO to have subsequent renewal options generally and in the event that the Parties decide not to extend this Agreement or if this Agreement is otherwise terminated. In the event that the Parties mutually agree
in a written amendment to extend the Term of this Agreement, the Parties will mutually agree on terms to renew the lease for the Manufacturing Facility and the Manufacturing Equipment from FOUNDATION (or FOUNDATION’s Affiliate). 

  
 16 

	11.2	Agreement Termination for Breach, Default or Failure to Perform 

 If a Party becomes a
breaching Party (the “Breaching Party”) by breaching, defaulting or failing to perform any representation, warranty, covenant, obligation or agreement hereunder in any respect that is material to this Agreement, then the other Party (the
“Non-Breaching Party”) may terminate this Agreement through a written notice to the Breaching Party (the “Breach Notice”) enumerating the Breaching Party’s breach(es) or failure(s) to perform or event(s) of default under
this Agreement; provided, that within sixty (60) calendar days after the date upon which the Breach Notice was delivered to the Breaching Party, the Breaching Party shall be entitled to cure any of the breaches, failures to perform or events of
default identified in the Breach Notice. If at the end of the 60-day cure period, any of the identified breaches, failures to perform or events of default have not been cured, the Non-Breaching Party may, by a signed written notice, terminate this
Agreement with respect to the Breaching Party, effective immediately. Notwithstanding the above, if the Breaching Party commences to cure the breaches, failures to perform or events of default identified in the Breach Notice within the 60-day cure
period, but is unable to reasonably complete the cure within such period, the Breaching Party shall, upon written notice to the Non-Breaching Party prior to the end of the original cure period, together with a reasonably detailed explanation of how
such cure would be achieved, have an additional 60-day cure period to complete the cure. The cure periods herein shall not apply to the Completion Deadline or the Milestone Events set forth in Sections 4.1(d) and 5.1(h). 

 

	11.3	Other Agreement Termination Events 

 If any Party (an “Affected Party”)
commits, engages in or suffers any of the following events, then the other Party may terminate this Agreement by written notice to the Affected Party: 

(a) Is dissolved or liquidated, files or has filed against it (and it is not dismissed within ninety (90) days of filing) a petition in
bankruptcy, reorganization, dissolution or liquidation or similar action, is adjudicated as bankrupt, or has a receiver appointed for its business; 

(b) Has all or a substantial portion of its capital stock or assets expropriated or attached by any government entity; 

(c) Makes an assignment of this Agreement for the benefit of creditors; or 

(d) Is subject to property attachment, court injunction, or court order materially affecting its ability to honor its obligations under this
Agreement. 
 (e) If a third-party obtains all or substantially all of the assets of SILEVO (which include the lease of the Manufacturing
Facility) and (i) such third party fails to agree in writing to be bound by all of the terms and conditions of this Agreement accruing thereafter as if such third-party instead of SILEVO was the original contracting party with FOUNDATION under
this Agreement and deliver such writing to FOUNDATION, and (ii) except as permitted under Section XVI, FOUNDATION declines to consent to such assumption (which consent shall not be unreasonably withheld by FOUNDATION). 

  
 17 

	11.4	Effects of Agreement Termination, Party Termination 

 (a) The Parties anticipate the need
for SILEVO to have renewal options generally and in the event that the Parties decide not to extend this Agreement or if the Agreement is otherwise terminated, the Parties will further discuss and document mutually agreeable renewal terms in the
lease. 
 (b) If a Party’s participation in this Agreement is terminated by another Party in accordance with Sections 11.2 or 11.3, such
Party shall be termed a “Terminated Party” herein, and the other Party (as to whose participation in this Agreement has not terminated) shall be termed the “Continuing Party” herein. 

(c) Any termination of the entire Agreement shall result in termination of all Projects and all other Program-related activities. Any
termination with respect to or withdrawal by a Terminated Party shall terminate the Terminated Party’s current and/or prospective participation in all Project activities as of the effective date of the Terminated Party’s termination, but
shall not relieve such Terminated Party of liability under Section 11.5 or as otherwise provided in this Agreement. 
 (d) Upon
termination of a Terminated Party’s participation in this Agreement, the Terminated Party shall destroy or return to the Continuing Party all Confidential Information (as defined in Exhibit E) of the Continuing Party, as well as all copies and
resumes thereof (except one (1) copy thereof which may be retained for archival and legal purposes), and the Terminated Party shall so certify such return or destruction in writing to the Continuing Party. 

  
 18 

	11.5	Liability upon Termination 

  

	 	(a)	If FOUNDATION is the Terminated Party, FOUNDATION’S total cumulative liability for the entirety of any remaining contributions and payments described in Sections IV or V of this Agreement shall not, under any
circumstances, exceed $750,000,000 until FOUNDATION has been awarded $750,000,000 by the State of New York, after which FOUNDATION’s total cumulative liability shall not, under any circumstances, exceed $750,000,000 minus any payments
previously made by FOUNDATION under Sections 4.1(c) or 5.1(a)-5.1(c). 

  

	 	(b)	If SILEVO is the Terminated Party, SILEVO’s total cumulative liability for the entirety of any remaining contributions, payments and obligations described in Section IV and Exhibit G hereof shall not, under any
circumstances, exceed the Unamortized Foundation Investment, less any amounts paid by SILEVO under Exhibit G. The “Unamortized Foundation Investment” means an amount equal to (i) the lesser of $750,000,000 and the amount actually expended
by FOUNDATION under this Agreement prior to the termination (excluding any amounts hereunder that are expressly to be at FOUNDATION’s sole cost and not subject to reimbursement or application to the caps set forth above), multiplied by
(ii) a percentage, the numerator of which is equal to the difference between (x) $5,000,000,000, and (y) the amount of capital, operational expenses and other costs incurred or spent by SILEVO through the effective date of
termination as provided in Article 4, and the denominator of which is equal to $5,000,000,000. 

  

	11.6	Failure of State Funding 

 FOUNDATION is reliant on the allocation of New York State
funds to satisfy FOUNDATION’s contribution obligations under Section 5.1 of this Agreement. In the event that the requisite New York State funding is not allocated to FOUNDATION, SILEVO shall have the right to terminate this Agreement as
provided in Section 5.1(i). Termination under this Section 11.6 shall not be regarded as termination for breach, default or failure to perform under Section 11.2 or other termination events under Section 11.3, but rather shall be
considered termination by reason of impossibility. FOUNDATION shall have no further obligations except those which apply to termination under this Section 11.6 or which otherwise survive termination as set forth in this Agreement. 

 

	XII.	PUBLICITY 

  

	 	12.1	Any press releases, public announcements, and publicity regarding this Agreement, the relationship between the Parties, or the content and results of Projects must be approved by both Parties in writing prior to any
press release, public announcement, or other publicity by either Party or by the State of New York, excluding any non-public communication that is internal to any individual Party or used solely by the Parties within the Program. 

 

	 	12.2	Subject to 12.3, a Party may publicly reveal the existence of and the total contribution amounts under this Agreement only with prior consent of the other Party. 

  
 19 

	 	12.3	SILEVO may disclose this Agreement to any potential or actual investor, provided that (a) such investor executes a standard non-disclosure agreement consistent with the terms of this Agreement, (b) SILEVO
provides notice of the disclosure to FOUNDATION within seven (7) days after the date of the disclosure, and (c) in the event of a related breach by such investor of the non-disclosure agreement, SILEVO shall immediately notify FOUNDATION
of such breach and provide FOUNDATION with all information related to such breach. A Party may also disclose this Agreement (a) in order to comply with its or any of its Affiliate’s obligations under applicable law, including securities
laws and the rules of any national securities exchange and (b) as permitted under Section 5(b) of Exhibit E. 

  

	 	12.4	Any public use by either Party of the names or logos associated with the other Party requires the prior written consent of the other Party. 

 

	XIII.	CONFIDENTIAL INFORMATION 

 The Parties agree that the terms set forth in Exhibit E
of this Agreement shall govern the handling of Confidential Information disclosed by a Party to another Party prior to or during the Term of this Agreement. 
  

	XIV.	INTENTIONALLY OMITTED 

  

	XV.	REPRESENTATIONS/WARRANTIES/LIABILITIES/INDEMNIFICATION 

  

	15.1	As of the Effective Date, SILEVO and FOUNDATION represent and warrant, as applicable, the following: 

  

	 	(a)	Each Party has the authority to enter into this Agreement and perform its obligations under this Agreement and any other documents and instruments contemplated hereby to be executed and delivered by such Party.

  

	 	(b)	The execution, delivery and performance by such Party of this Agreement and all of the documents and instruments contemplated hereby to be executed and delivered by such Party are within the legal power and authority of
such Party and have been duly authorized by all necessary action of such Party. This Agreement is, and the other documents and instruments required hereby to be delivered by it will be, when executed and delivered, the valid and binding obligations
of such Party, enforceable against such Party in accordance with their respective terms. 

  

	 	(c)	The execution, delivery and performance of this Agreement and all of the other documents and instruments contemplated hereby to be executed and delivered by such Party does not and will not conflict with or violate any
material judgment, order or decree binding on such Party. 

  

	 	(d)	Such Party has the full right, power and authority to grant any licenses to be granted by such Party pursuant to this Agreement. 

  

	 	(e)	There are no outstanding agreements, assignments or encumbrances that have been made by such Party and by which such Party is bound and that are inconsistent with or are violated by the provisions of or granting of such
licenses. 

  
 20 

	 	(f)	There is no litigation, governmental investigation, suit, action, proceeding or written claim of any kind pending and to the Knowledge of SILEVO, none are threatened against SILEVO or any of its subsidiaries or
affiliates adversely affecting the ability of SILEVO to perform its obligations under this Agreement. 

  

	15.2	Injunctive Relief  

 Either Party may seek to enforce any of the specific provision(s) of
this Agreement by commencing an action for injunctive or other equitable relief at any time. 
  

	15.3	Limitations of Liability  

  

	 	(a)	Except for (i) a Party’s failure to make the specific payments, contributions, deliveries or provide the services or support under Sections IV and V of this Agreement, (ii) a Party’s respective
obligations under Sections VIII, 12.3, and XIII, and (iii) matters or claims in respect of this Agreement that relate to workers compensation, bodily injury, death, sickness, disease, disability and damage or destruction to real or personal
property, tools and equipment, each Party’s total cumulative liability for any and all matters, causes of action or indemnifications in any way relating to this Agreement or for the performance or non-performance or breach of any
representation, warranty, covenant, duty or obligation under this Agreement, regardless of the form of action, shall be limited to damages and/or payments which shall not exceed $5 Million, in the aggregate. 

 

	 	(b)	With respect to only subsections (i) and (iii) of Section 15.3(a) of this Agreement, each Party’s total cumulative liability for any and all matters, causes of action or indemnifications (including,
but not limited to, Section 15.5 of this Agreement) in any way relating to such subsections or for the performance or non-performance of any covenant, duty or obligation thereunder, regardless of the form of action, shall be limited to damages
and/or payments which shall not exceed in the aggregate (1) with respect to Section 15.3(a)(i) of this Agreement, the limits under Section 11.5, as to matters addressed in Section 11.5, and (2) with respect to
Section 15.3(a)(iii) of this Agreement, only for those matters or claims that relate to damage or destruction to real or personal property, tools and equipment to the extent such matters or claims are not covered by insurance that is required
to be carried by a party under this Agreement or under the lease or use agreement or similar agreement for the Manufacturing Facility and Manufacturing Equipment, in each case of such damage or destruction, equal to the sum of (i) the insured
value of the real or personal property, tools and equipment, and (ii) $5 Million, in the aggregate. 

  

	 	(c)	Notwithstanding anything to the contrary contained elsewhere in this Agreement, the Parties agree that any liability or obligations under this Agreement shall not include any special, punitive, indirect, incidental or
consequential damages, including, but not limited to, lost profits, even if a Party has been made aware of the possibility of such damages. 

  
 21 

	15.4	Insurance 

 SILEVO and FOUNDATION shall obtain the insurance coverage and/or limits in
accordance with Exhibit F and each agrees to the terms set forth in Exhibit F. 
  

	15.5	Indemnification  

  

	 	(a)	(i) Each Party (the “Indemnitor”) to this Agreement shall, subject to the limitations set forth in Section 11.5 and Section 15.3, indemnify, save, hold harmless and defend the other Party and
its officers, directors, managers, shareholders, employees, agents, advisors and assigns (collectively, “Party Indemnitee”) and (ii) SILEVO, as Indemnitor, shall also, subject to the limitations set forth in Section 11.5 and
Section 15.3, indemnify, save, hold harmless and defend FSMC, CNSE, SUNY IT, the State of New York and SUNY, and their officers, directors, managers, shareholders, employees, Affiliates, Subsidiaries, agents, advisors and assigns (“SUNY
Indemnitee”, and collectively with each Party Indemnitee, an “Indemnitee”), in each case from and against any and all claims (including, without limitation, third party claims), damages, demands, actions, judgments, lawsuits,
proceedings, assessments, liabilities, losses, penalties, costs and expenses (including, without limitation, reasonable attorneys’ fees, costs and expenses, whether incurred in a third party action or in an action to enforce this Agreement),
whether or not subject to litigation (collectively, “Indemnified Claims”), incurred by any Indemnitee in connection with, by reason of, or arising out of (A) the breach, untruthfulness or inaccuracy of any representation or warranty
of the Indemnitor that is contained in this Agreement, (B) the breach or failure to keep, observe or perform any covenant or obligation of the Indemnitor in this Agreement, (C) any fraud of the Indemnitor (or its employees or agents) in
connection with the performance of this Agreement, (C) any damage or destruction of third party property, or injury, sickness, disease or death to persons, resulting from the Indemnitor’s or its employees’ or agents’ negligence
or misconduct, or (D) any act or omission or violation of statutory duty or regulation by the Indemnitor or any of its employees or agents. SILEVO shall also defend, indemnify and hold harmless FOUNDATION and FOUNDATION Affiliates as set forth
herein, in connection with any goods and/or services arising under this Agreement, provided, made, sold and/or transferred by SILEVO and in connection with any breach by an investor of a non-disclosure agreement entered into by SILEVO pursuant to
Section 12.3. 

  
 22 

	 	(b)	An Indemnitee, for purposes of asserting the indemnifications under this Section, will give the applicable Indemnitor written notice of any Indemnified Claim within thirty (30) days after the Indemnitee
(a) receives notice of an Indemnified Claim for which indemnification is sought or (b) determines that an event of which it is aware is likely to give rise to an Indemnified Claim for indemnification, and the Indemnitee will give copies to
the Indemnitor of all information and documents relating to such Indemnified Claim or potential Indemnified Claim that are received by the Indemnitee within thirty (30) days after the Indemnitee’s receipt thereof or, if applicable, within
thirty (30) days after the Indemnitee makes the determination referred to in clause (b); provided, that the failure of the Indemnitee to give notice or deliver copies of information or documents within the specified time periods shall not limit
the Indemnitee’s right to claim indemnification hereunder, except to the extent that the Indemnitor can demonstrate that it was actually damaged by the failure to give notice or provide information or documents within the specified time
periods. The applicable Indemnitor will be obligated to defend any Indemnified Claim for indemnification hereunder, and to select counsel for any third-party Indemnified Claim, which counsel shall be reasonably satisfactory to the Indemnitee, all at
the sole cost and expense of the Indemnitor; provided, that the Indemnitee will be allowed, at its expense, to participate in such defense; provided, further, that no settlement shall be entered into without the approval of the Indemnitee; provided
further, that in the event the Indemnitor proposes in good faith to settle an Indemnified Claim that requires solely the payment of money damages by the Indemnitor on terms acceptable to the third-party claimant and the Indemnitor is ready, willing
and able to completely satisfy the Indemnified Claim on such terms but the Indemnitee does not consent to the settlement on such terms, the Indemnitee shall be responsible for all liability or expenses (including reasonable legal expenses and costs)
with respect to such Indemnified Claim that exceed the proposed settlement amount, including all legal expenses and costs incurred after the date the Indemnitee initially gave notice to the Indemnitor withholding its consent to the proposed
settlement. Notice of the Indemnitor’s intention to defend any such Indemnified Claim shall be given to the Indemnitee within twenty (20) days after the Indemnitee shall have notified the Indemnitor of the Indemnified Claim (but in all
events at least five (5) business days prior to the date that an answer or other response is due to be filed or made), which notice shall contain an acknowledgment in writing of the Indemnitor’s obligation to indemnify the Indemnitee with
respect to such Indemnified Claim under this Section. In the event the Indemnitor fails or elects not to defend any such Indemnified Claim hereunder, the Indemnitee shall have the right to so defend such Indemnified Claim at the sole obligation,
cost and expense of the Indemnitor. 

  

	 	(c)	The indemnifications set forth in this Agreement shall remain operative and in full force and shall survive the execution and performance hereof and the termination or expiration of this Agreement, as well as the
withdrawal of either Party from this Agreement for any reason. 

  

	15.6	Limitation of FOUNDATION Representations and Warranties 

 Except to the extent described
in this Agreement, FOUNDATION makes no representation or warranty, express or implied, with respect to the condition or suitability of the CNSE Tools, the Manufacturing Equipment, CNSE Facilities or any part thereof in respect of the operations and
activities of the Program, including but not limited to any implied warranties of merchantability or fitness for a particular purpose, or warranty of non-infringement of third party intellectual property rights. 

 

	15.7	Maintenance and Repairs 

 FOUNDATION will manage the design and construction of the
Manufacturing Facility, subject to SILEVO’s rights under Section 5.1(b). FOUNDATION shall keep the foundation, the exterior walls, plate glass windows, exterior entrance doors, exterior entrance door closure devices, and other exterior
openings; window and window frames, molding, locks, and hardware; signs, placards, decorations or advertising media of any type, underground utilities and roof of the Manufacturing Facility and furnace in good repair. FOUNDATION will keep SILEVO
apprised, where applicable, of maintenance and repair work to the Manufacturing Facility and will coordinate any such maintenance and repair work with SILEVO so as to minimize the disruption of the Manufacturing Operations. 

  
 23 

 SILEVO shall be responsible for the maintenance and repair of the Manufacturing Equipment. SILEVO
shall make all needed repairs and replacements of the Manufacturing Equipment, within the Manufacturing Facility (including all utility systems located either within or above ground on the outside perimeter of the Manufacturing Facility), except for
repairs and replacements required to be made by FOUNDATION hereunder. 
 In the event the Manufacturing Equipment should become in need of
maintenance or repair required to be made by SILEVO hereunder, SILEVO shall give prompt written notice thereof to FOUNDATION reasonably describing the maintenance and repair work to be performed, the Manufacturing Equipment affected, and proposed
treatment; but in the event a condition arises with respect to the Manufacturing Equipment that either (i) creates a materially unsafe condition or imminent danger to persons with respect to the Manufacturing Equipment, or (ii) materially
impairs the Manufacturing Equipment, as determined by FOUNDATION, FOUNDATION may make immediate interim repairs as are necessary to prevent damage from occurring. FOUNDATION and SILEVO shall work together to coordinate maintenance and repair under
any available warranties. FOUNDATION may appoint SILEVO as its agent to enforce all such express warranties with respect to the Manufacturing Equipment on a case by case basis, to allow SILEVO to undertake needed maintenance and repairs on an
expedited basis when necessary to minimize downtime and impact on the Manufacturing Operations. 
 In the event the Manufacturing Facility
should become in need of maintenance or repair required to be made by FOUNDATION hereunder, FOUNDATION shall give prompt notice thereof to SILEVO; but in the event of a materially unsafe condition or imminent danger to persons with respect to the
Manufacturing Facility, as determined by FOUNDATION, FOUNDATION shall make immediate interim repairs as are necessary to prevent damage from occurring. 

Notwithstanding anything to the contrary contained in this Section 15.7, if a condition arises with respect to the Manufacturing Facility
that either (i) creates a materially unsafe condition or imminent danger to persons, or (ii) materially impairs the manufacturing capacity or operation of the Manufacturing Operations, SILEVO shall provide prompt written notice thereof to
FOUNDATION and FOUNDATION shall take commercially reasonable steps to address the condition, taking into account the urgency of the situation. 

Where appropriate, FOUNDATION shall cooperate with SILEVO (e.g., assigning warranty rights) to enable SILEVO to address the condition. 

 

	15.8	SILEVO Assumption of Risk 

 Except to the extent due to the negligence, willful
misconduct or violation of laws or this Agreement by FOUNDATION or its Affiliates or their respective employees, agents or contractors, SILEVO assumes all risks involved in the use of the Manufacturing Facility and Manufacturing Equipment, and shall
be solely responsible for any and all accidents and injuries to persons and property which relate to SILEVO’s use of and access to the Manufacturing Facilities and Manufacturing Equipment in respect of the operations and activities of SILEVO
under this Agreement and SILEVO agrees to accept the Manufacturing Facilities and the Manufacturing Equipment in the condition required under this Agreement. 

  
 24 

	15.9	Execution, Delivery and Performance 

 The Parties represent and warrant that the
execution, delivery and performance of this Agreement does not and will not violate or create any material conflict with any of the terms or conditions of another agreement to which they are parties. 

 

	15.10	Hazardous Materials 

 Notwithstanding anything to the contrary in this Agreement,
including Sections 4.1(e), 4.2, 4.3, 5.1, and 15.8, SILEVO shall not have any liability or obligation with respect to any Hazardous Materials located on or about the Site (including the soil, surface water or groundwater) or in the Manufacturing
Facility (including building materials) currently or in the future that are not released, discharged, spilled or brought onto the Site by SILEVO or its employees, agents or contractors, including additional costs in constructing the Manufacturing
Facility (including any vapor intrusion mitigation) that are attributable to any Hazardous Materials not released, discharged, spilled or brought onto the Site by SILEVO or its employees, agents or contractors or any ongoing monitoring, mitigation
or remediation at the Site for any Hazardous Materials located on or about the Site currently (including any vapor intrusion mitigation) or in the future that are not released, discharged, spilled or brought onto the Site by SILEVO or its employees,
agents or contractors (and the $350 Million and $750 Million amounts referenced in
 Sections 5.1(a), (c), (d) and (h) and Exhibit A shall not be applied toward such costs). SILEVO shall indemnify and defend FOUNDATION
FSMC, CNSE, SUNY IT, the State of New York and SUNY, and their officers, directors, managers, shareholders, employees, Affiliates, Subsidiaries, agents, advisors and assigns in accordance with 15.5(a) with respect to any Hazardous Materials
released, discharged, spilled or brought onto the Site by SILEVO or its employees, agents or contractors in violation of law. “Hazardous Material” shall mean any material which is now or hereafter regulated by any governmental authority
which poses a hazard to the environment or human health. 
  

	XVI.	ASSIGNMENT 

 A Party may not assign this Agreement or any of rights afforded hereunder
without the prior written consent of the other Party, which consent shall not be unreasonably withheld, except that SILEVO may assign this Agreement to SolarCity Corporation (“SolarCity”) or any Affiliate of SolarCity. Notwithstanding the
foregoing, (i) SILEVO shall not be required to obtain FOUNDATION’s prior written consent if (A) a third party(ies) acquires all or substantially all of the shares of stock of SILEVO, although SILEVO shall provide FOUNDATION with
advance written notice of the identity of such third party(ies) and the general nature of the transaction, or (B) a third party (ies) acquires all or substantially all of the assets of SILEVO related to this Agreement, and the third party(ies)
agrees to assume all of the obligations of SILEVO under this Agreement accruing thereafter, and (ii) without limiting the foregoing, SILEVO may assign this Agreement or sublet portions of the Manufacturing Facility to an Affiliate of SILEVO or
an entity otherwise related to SILEVO by merger, consolidation or reorganization. In addition, SILEVO may not otherwise allow any other party, person or entity access to or use of the CNSE Tools or the CNSE Facilities, except employees of
SILEVO’s Affiliates or other entities described in this paragraph above, or contractors, suppliers, customers, or investors thereof, provided they meet the same requirements imposed on SILEVO employees by FOUNDATION. Any assignment made in
violation of this Section shall be void ab initio. 

  
 25 

	XVII.	COMPLIANCE WITH LAWS, REGULATIONS AND RULES 

  

	17.1	Each Party agrees to comply with all applicable laws, rules and regulations of the State of New York, the United States Government and of any other duly constituted governmental authority having jurisdiction over such
Party, to the extent applicable to the activities under this Agreement and as may be updated by the applicable governmental authority from time to time. The transfer of certain technical data and commodities may require a license from the cognizant
agency of the United States Government and SILEVO represents and warrants that it will not re-export data or commodities to certain foreign countries or nationals of certain foreign countries without prior approval of the cognizant government
agency. While FOUNDATION agrees to cooperate in pursuing any license that the cognizant agency deems necessary in connection with this Agreement, FOUNDATION cannot guarantee that such licenses will be granted. Each Party shall do all things
necessary (a) to obtain in a timely manner all required licenses and approvals related to the activities under this Agreement and (b) to comply with all applicable laws, rules and regulations, including, but not limited to, the regulations
of the United States Government relating to the export and re-export of technical data and commodities, related to the activities under this Agreement. In addition to the foregoing, SILEVO covenants that it will provide written certification by an
authorized officer of the applicable corporation(s) that any export or re-export of any technical data and commodities related to activities under this Agreement will have a valid United States Department of Commerce export license or that no export
license is required. SILEVO will not integrate, promote, sell or otherwise transfer any technical data and/or commodities under this Agreement to any customer or end user for use in any military applications (other than military housing and
buildings). The Parties hereby acknowledge that stricter United States Government regulations may apply to the export and re-export of technical data and commodities to any of the following countries or to the nationals of any of the following
countries: Armenia, Azerbaijan, Belarus, Bulgaria, Cambodia, Cuba, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Iran, Iraq, Laos, Latvia, Libya, Lithuania, Macao, Moldova, Mongolia, North Korea, People’s Republic of China, Romania, Russia, Sudan,
Syria, Tajikistan, Turkmenistan, Ukraine, Uzbekistan, and Vietnam or as updated by the U.S. Department of Commerce. SILEVO has existing research and manufacturing relationships with companies in China, but SILEVO shall only export or re-export
technical data and commodities to companies in China in compliance with applicable laws, rules and regulations and pursuant to applicable licenses and approvals. 

  

	17.2	Each Party represents and covenants that it has, or will have in place, established procedures and/or agreements with its employees, agents or others, including subcontractors, whose services the Party may require to
fulfill the terms and conditions of this Agreement, sufficient to enable such employees, agents or others to comply with all the terms and conditions of this Agreement, and covenants that it shall require these employees, agents or others, including
subcontractors, and any third-party visitor or guest to the CNSE Facilities, to agree to necessary and sufficient confidentiality and intellectual property provisions in writing. Each Party shall be responsible for the selection and screening of its
employees, agents or others who will be assigned to work on the Program. Each Party will ensure, by management direction and if necessary by contract, that its employees, agents or others comply with the laws, rules and regulations of the State of
New York, the United States Government and of any other duly constituted governmental authority having jurisdiction over such Party, as well as, the personnel, security and safety practices, procedures and requirements of the CNSE and FOUNDATION
while such employees, agents or others are at the CNSE Facilities. Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement shall be interpreted such that any person who is not an actual employee of a Party or, in the
case of FOUNDATION, an actual employee of an Affiliate, shall be treated or construed as a common law employee of such Party. 

  
 26 

	XVIII.	LITIGATION/ APPLICABLE LAW/ JURISDICTION/ SERVICE 

  

	18.1	The Parties shall attempt in good faith to promptly resolve any controversy, claim or dispute arising out of this Agreement, first in accordance with the provisions of Section X of this Agreement, and then, if the
provisions of Section X of this Agreement are not successful, either Party may bring a legal action or proceeding to resolve such controversy, claim or dispute only in any United States District Court or in any state court of the State of New York,
in each case located in the State of New York that has jurisdiction over such controversy, claim or dispute. Each Party hereby consents to exclusive jurisdiction and venue of such courts. This Agreement shall be construed and the legal relations
created herein between the Parties shall be determined in accordance with the substantive laws of the State of New York, without regard to the conflict of laws principles thereof. In such court proceedings, the Parties agree to submit an appropriate
protective order to the court to protect each Party’s Confidential Information. The Parties hereby expressly waive any right to a jury trial for any legal action or proceeding brought under this Agreement and agree that any legal action or
proceeding hereunder shall be tried by a judge without a jury. 

  

	18.2	All communications, notices and disclosures required or permitted by this Agreement shall be in writing, shall be provided to the other Party and shall be deemed to have been given at the earlier of the date when
actually delivered to the other Party or three (3) business days after being deposited in the United States mail, certified or registered mail, postage prepaid, return receipt requested, upon delivery if delivered by hand delivery, or one
(1) business day after being deposited with a reputable overnight courier service with signed receipt, and addressed as follows, unless and until either Party notifies the other Party in accordance with a change of address: 

In the case of FOUNDATION: 

College of Nanoscale Science and Engineering 

NanoFab 300 East 
 257 Fuller Road

 Albany, NY 12203 
 Attn:
Christine Waller, Operations Manager 
 With a copy to: 

College of Nanoscale Science and Engineering 

NanoFab 300 East 
 257 Fuller Road

 Albany, NY 12203 
 Attn: Carl
J. Kempf III, Esq., CNSE Associate Vice President for Policy and Regulatory Affairs 
 ckempf@sunycnse.edu 

  
 27 

 In the case of SILEVO: 

Silevo, Inc. 
 45645-45655
Northport Loop East 
 Fremont, CA 94538 

Attn: Chris Beitel 
 Facsimile No.
(510) 771-1370 
 With a copy to: 

Wilson Sonsini Goodrich & Rosati 

Professional Corporation 
 650
Page Mill Road 
 Palo Alto, CA 94304 

Attn.: Steven V. Bernard 
  

	XIX.	MISCELLANEOUS 

  

	19.1	Each Party agrees not to use each other’s names, the names of any staff members or employees thereof, or trademark or other designation of either Party hereto, in advertising, sales promotion work, or in any other
form of publicity except with the written permission of, and to the extent approved by the Party whose name is to be used. 

  

	19.2	If any term or provision of this Agreement or the application thereof to either Party hereto or set of circumstances shall, in any jurisdiction and to any extent, be finally held to be invalid or unenforceable, such
term or provision shall only be ineffective as to such jurisdiction, and only to the extent of such invalidity or unenforceability, without invalidating or rendering unenforceable any other terms or provisions of this Agreement or under any other
circumstances, so long as the remainder of this Agreement still effectuates the Essential Purposes. If the Essential Purposes cannot be effectuated, this Agreement shall be renegotiated and amended with the unanimous consent of the Parties, which
will not be unreasonably withheld, or may be terminated without cause by either Party. 

  

	19.3	The failure of either Party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that Party of the right to insist later on adherence thereto, or
thereafter to insist upon strict adherence to that term or any other term of this Agreement. To be effective, any waiver must be in a writing signed by an authorized representative of the Party granting such waiver. 

 

	19.4	The headings in this Agreement are intended solely for convenience of reference and shall be given no effect in the construction or interpretation of this Agreement. The terms “herein”, “hereof”,
“hereunder” and any similar terms used in this Agreement refer to this Agreement and all references to “this Agreement” refer to this instrument and the Exhibits hereto, as amended from time to time. The terms
“including” or “include” shall mean “including, without limitation”, or “include, without limitation.” 

  
 28 

	19.5	If either Party is rendered wholly or partially unable by Force Majeure to carry out its obligations under this Agreement, and if that Party gives prompt written notice, including a reasonable description of such Force
Majeure, to the other Party, the notifying Party shall be excused from performance of its obligations hereunder during the continuance of any inability so caused, but for no longer period. Such cause shall be remedied by the notifying Party as far
as possible with reasonable speed and effort, but neither Party shall have any obligation to settle any labor dispute. For the purposes of this Agreement, “Force Majeure” shall mean Acts of God, labor disputes, acts of public enemies or
terrorists, war, other military conflicts, blockades, insurrections, riots, epidemics, quarantine restrictions, landslides, lightning, earthquake, fires, conflagration, storms, floods, washouts, arrests, civil disturbances, restraints by or actions
of any governmental body (including export or security restrictions on information, material, personnel, equipment or otherwise), industry-wide shortages, industry-wide unavailability, and any other acts or events whatsoever, whether or not similar
to the foregoing, not within the control of the Party claiming excuse from performance, which by the exercise of the diligence and reasonable efforts that Party shall not have been able to overcome or avoid. If the notifying Party cannot remedy the
Force Majeure situation and resume satisfactory performance within ninety (90) days after delivery of the notice, the other Party may at their option immediately terminate this Agreement and such notifying Party will be treated as a Terminated
Party under Section 11.4 hereof; provided such time limit shall not apply to SILEVO’s inability to perform its obligations under Section IV due to casualty damage to the Manufacturing Facility. The provisions of this Section 19.5
shall not serve to extend the Completion Deadline or the Milestone Events set forth in
 Section 4.1(d) or Section 5.1(h). 

  

	19.6	Each Party shall be responsible for all tax matters, issues or obligations related to the employment of its employees or agents or to the presence of its personal property in any taxing jurisdiction. 

 

	19.7	During the Term of this Agreement, neither Party shall solicit for employment purposes any employees of the other Party (and in the case of FOUNDATION, FOUNDATION Affiliates) who have performed or are performing
Program-related work under this Agreement. Neither Party shall make any payment or any gift of more than a nominal value to any employee of a Party without the employing Party’s prior concurrence. Neither Party shall make any representation
that an employment relationship exists between that Party and an employee of another Party. The above portions of this Section shall not restrict (a) the ability of the Parties to conduct general solicitations for employment, (b) the right
of any employee of a Party, on that employee’s own initiative or in response to general solicitations, to seek employment from the other Party, or (c) the ability of SILEVO to solicit students employed or working at the CNSE Facilities.

  

	19.8	To the extent a particular right, obligation, representation, warranty, covenant or indemnity in this Agreement does not have a specifically identified survival period, then such right, obligation, representation,
warranty, covenant and/or indemnity shall remain in effect beyond any expiration or termination of this Agreement and shall bind and inure to the benefit of the Parties, their legal representatives, successors and permitted assigns. Particular
Sections of this Agreement that survive any termination or expiration of this Agreement include, but are not limited to, Sections VIII, XIII, and XV hereof. 

  
 29 

	19.9	No amendment or modification of this Agreement shall be valid or binding upon the Parties unless in a writing executed by both of the Parties. 

 

	19.10	Neither the provisions of this Agreement nor anything done pursuant to this Agreement shall create any partnership, any employer-employee relationship or any agency relationship between the Parties and the Parties are
otherwise independent contractors relative to each other. 

  

	19.11	Nothing in this Agreement shall obligate either Party to institute any action or suit against third-parties for infringement of any of its patents, or to defend any action or suit brought by a third-party that
challenges or concerns the validity of any of its patents. Nothing in this Agreement shall grant either Party the right to institute any action or suit against third-parties for infringement of the other Party’s patents. Nothing in this
Agreement shall obligate either Party, nor any of its Subsidiaries, to file any patent application, to secure any patent or patent rights, or to maintain any patent in force. 

 

	19.12	This Agreement, together with the Exhibits hereto, any SOW(s) entered into by the Parties pursuant to Section IX, and any follow on contracts and/or amendments entered into by the Parties pursuant to Sections 2.7, 2.8,
4.2, 5.1 or 11.1 of this Agreement, if and as signed by the Parties, is the complete and exclusive statement of the agreement of the Parties in respect of the subject matter described in this Agreement and shall supersede all prior and
contemporaneous agreements, communications, representations, and understandings, either oral or written, between the Parties or any officers, agents or representatives thereof. Notwithstanding anything to the contrary set forth herein, this
Agreement shall be valid and binding notwithstanding that subsequent agreements and/or amendments are contemplated hereby. 

  

	19.13	This Agreement may be signed in one or more counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute the same Agreement. Any signed copy of this Agreement made
by photocopy, facsimile or PDF Adobe format shall be considered an original. 

  

	19.14	This Agreement and the obligations of the parties hereto are conditioned upon the occurrence of the following within sixty (60) days of the Effective Date: (a) the closing of the acquisition of SILEVO by SolarCity
Corporation, a Delaware corporation; and (b) the entry by the FOUNDATION or FSMC and contractor(s) into construction contract(s) reasonably acceptable to SILEVO for the construction of the Manufacturing Facility. 

  
 30 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed and delivered by their duly
authorized representatives as of the Effective Date. 
 THE RESEARCH FOUNDATION FOR 

THE STATE UNIVERSITY OF NEW YORK 
  

			
	 By:
	 	 /s/ Christine Waller

	 Name:
	 	Christine Waller
	 Title:
	 	Operations Manager
	 Date:
	 	September 4, 2014

  

			
	 SILEVO, INC.

 

	 By:
	 	 /s/ Zheng Xu

	 Name:
	 	Zheng Xu
	 Title:
	 	CEO
	 Date:
	 	September 3, 2014

  
 31 

 EXHIBIT A 

TERMS AND CONDITIONS RELATED TO PARTY PROGRAM CONTRIBUTIONS 
  

			
	MANUFACTURING OPERATION	  	 SILEVO shall locate the Manufacturing Operation at the Site.

Subject to the other terms set forth in the Agreement, FOUNDATION shall provide a total funding of $750,000,000 U.S. for the Manufacturing Facility and
Manufacturing Equipment. The total funding by FOUNDATION excludes any costs associated with land, which shall be provided at FOUNDATION’s sole cost.

Subject to the other terms set forth in the Agreement, FOUNDATION shall provide $400,000,000 of the total funding for Manufacturing Equipment, which is subject
to the terms set forth in Exhibit G.

		
	FACILITY AND EQUIPMENT OWNERSHIP	  	 FOUNDATION shall own the Manufacturing Facility and Manufacturing Equipment.

Subject to Section VIII of the Agreement, SILEVO shall own any and all of the proprietary technology necessary and useful for manufacturing the Triex products.
Except for the Manufacturing Facility that will be owned or controlled by or on behalf FOUNDATION and the Manufacturing Equipment that will be owned by FOUNDATION and made available for Manufacturing Operations, SILEVO owns all the inventory,
product, output, and other property it purchases or creates associated with running the operations of the Manufacturing Operation.

		
	LEASE	  	SILEVO shall lease the Manufacturing Facility and Manufacturing Equipment for the Manufacturing Operations from FOUNDATION or FOUNDATION Affiliate for a period of ten years for the sole consideration of one dollar $1.00 US per
year, subject to the terms set forth in Exhibit G for the Manufacturing Equipment.
		
	TIME SCHEDULE AND RAMP	  	SILEVO shall jointly commission, with FOUNDATION, the Manufacturing Operation as soon as possible, and SILEVO shall exercise commercially reasonable efforts to ramp up production of its Triex PV modules to Full Production Output
(as defined in Section 4.1(b)) within three months after Manufacturing Equipment Commissioning (as defined in Section 4.1(b)) and to achieve Full Production Output within six months after Manufacturing Equipment Commissioning. SILEVO will cover all
costs associated with operation of the Manufacturing Facility as provided in the Agreement.
		  	
		
	SILEVO’S INVESTMENT	  	As provided in the Agreement, SILEVO commits to invest and spend in the Manufacturing Operation at a level that ensures competitive product costs as determined by the market place for a minimum of five years. For planning
purposes, it is anticipated that SILEVO will spend or incur approximately $5 Billion in combined capital, operational expenses and other costs in New York State (as described in Section 4.3(c)), including at its next generation manufacturing,
business and related operation in Western New York, during the ten (10) year period commencing with Full Production Output.
		
	JOB CREATION	  	As provided in the Agreement, SILEVO shall employ 1,460 people for the purpose of operating the Manufacturing Operation and 2,000 people for support of downstream sales and installation activities within New York State. SILEVO
also commits to working jointly with FOUNDATION to assist it in attracting and locating additional 1,440 high tech jobs from companies that provide contracting, supplies, support, services, machinery, equipment, materials, provisions, construction
and maintenance and any other activity, service or good related to the business provided and generated by SILEVO.

 EXHIBIT B-1 

MANUFACTURING FACILITY REQUIREMENTS 

EXHIBIT IS SUBJECT TO MODIFICATIONS AS JOINTLY DETERMINED BY SILEVO AND FOUNDATION AS SILEVO AND FOUNDATION JOINTLY ENGAGE THE DEVELOPER TEAM TO FINALIZE
BUILDING SPECIFICATIONS, LOCATION, AND SITE SPECIFICATIONS. 
 The following design parameters descriptions are based on detailed meetings, discussions
and collaborations between the LPCiminelli (LPC) design team, including EYP Architecture & Engineering, P.C. (EYP) and M+W Group U.S. (M+W), with CNSE. 
  

	A.	Overall Site Improvements 

 For narrative description of the site improvements, site
infrastructure and sub-foundation piles supporting the building, see the separate Site Design Parameters Description. 
  

	B.	Building Core & Shell Enclosure 

 The primary Facilities consists of a steel
superstructure with “H” shaped columns on a standardized 40 ft. X 50 ft. bay with modified approximate 13 ft. bays as required to meet the manufacturing and equipment-tool placement requirements, with steel truss roof members, supported on
wide-flange (“WF”) steel girders typically. The overall facility within the manufacturing and manufacturing support areas is a one-story (approximately 32 ft. clear height to bottom of roof trusses) structure with the introduction of five
(5) mechanical mezzanines of approximately 40 ft. X 500 ft. in dimension located over the manufacturing spaces, within the overall height of the one-story structure. The administrative office block-area is anticipated to be a taller one-story
(18’ to bottom of steel) steel framed structure of standard H-columns and WF-girders/beams construction. The manufacturing staff entry/locker/circulation corridor, which runs North-South along the East edge of the Facility (facing the parking),
is anticipated to be a lower one-story (9 ft. to bottom of steel) structure of steel frame construction. 
 For pile-support sub-foundations,
supporting the building, see the separate narrative for Site Design Parameters Description. 
 Mezzanines have been designed to accommodate
uniform supported loads of 150 psf, with limited areas for electrical equipment at ends at a higher 250 psf. 
 The overall structure is
anticipated to be of Type 1B construction throughout and fully protected by a fire-sprinkler suppression system, with reductions in fire rating based on the same. The structure is anticipated to have fire-rated columns and mezzanine
floor-girder/beams, with cementicious spray-on fireproofing typically, and no fire proofing applied to the roof and/or roof trusses within the one-story high-bay areas, based on the anticipation of a waiver to be granted for the facility type, use
and height, to be obtained by LPC-CNSE. 
  

	C.	Functional Spaces for Tenant Improvements 

 The overall Facility includes the following specific
functional space types, totaling 1,125,870 gross square feet (gsf), which have been identified in an accompanying general floor plan layout diagram, summarized as follows: 
  

							
	1.     Manufacturing H5 Areas	  	-	 496,620 gsf	  	  	
	2.     Panel Assembly Area F1 Areas	  	-	 190,940 gsf	  	  	
	3.     Warehouse Areas F1 & H5 (combined)	  	-	 45,330 gsf	  	  	
	4.     Office B Areas	  	-	 24,850 gsf	  	  	
	5.     Mechanical Mezzanines F1-H5	  	-	 123,190 gsf	  	  	
	6.     Lockers-Entries-Circ. B Areas	  	-	 27,600 gsf	  	  	
	7.     Mechanical Utility Plant (CUP)	  	-	 110,780 gsf	  	  	
	8.     Electrical Utility Plant (CUP)	  	-	 20,000 gsf	  	  	
	9.     Process Support Plant H2, H3, H4 & F1	  	-	     86,660 gsf	  	  	
	TOTAL gsf Area	  	 	    1,125,970 gsf	  	  	

	D.	Building Life Safety & General Amenity Systems-Fitout 

 The Facility will be provided
with exit egress and fire ratings, as prescribed by the applicable codes, ordinances and standards, as modified by waiver through the authorities having jurisdiction (AHJ), and include: (1) Fire suppression sprinkler system throughout;
(2) fire alarm annunciation system throughout; (3) exist access-egress corridors, stairways and other devices; and (4) four exit passageways (3 full & 1 partial) within the manufacturing area that extend up from the
manufacturing floor to an elevated area traversing the width of the facility (within or alongside the mechanical mezzanine areas) and lead to areas of refuge at the East building façade near the parking and West yard areas, facing the river.

 General amenity and manufacturing-office support areas include two primary staff entry and toilet modules along the East side facing the
parking, with lockers along the corridor wall for manufacturing staff, based on the current operational requirements. The entry- toilets modules shall include limited shower and security check-points (card-access entry) for the entire facility, as
the primary point-of-entry for the facility. A limited card-access is anticipated to be provided at the manufacturing, warehouse and Central Utility & Process Support plant areas. 

 

	E.	Office Administrative Area Improvements-Fitout 

 The office area, including main entry lobby
entry for administrative office staff and visitors, a main conference room, limited number of smaller huddle-conference rooms and “bull-pen” type cubicles for approximately 100 manufacturing support office staff, with no requirement for
enclosed offices for management or executive staff. The office area is also to include an area to accommodate vending-coffee and a small limited menu, unsubsidized, outside food service operation (based on the size and staff type), with hours of
operation weekdays from approximately 7 AM through 2 PM. The food service operation is anticipated to require limited food storage and on-site food preparation space. The food service operation is anticipated to be supported by a moderately-sized
multi-purpose seating area for approximately 150 to 200 people, to accommodate staff on rolling shifts taking breaks during a 24-7/365 day/year operation, and used in off-shift times for casual meetings and training. 

 

	F.	Tele-data & Security Requirements 

 The facility is anticipated to be supported by a
standard voice-data approach to include copper twisted-pair (category 5 or 6) station cable infrastructure to standard voice-data outlets located within the office areas and on a limited basis throughout the manufacturing and other central utility
plant areas. Voice-data patch-down rooms shall be located within standard distances, based on maximum cable length transmission requirements for the copper station cable and be connected to a voice-data “File-server” room to be located in
the office area. Local voice-data rooms shall be connected back to the file server rooms by means of a fiber-optic cable backbone, with standard punch down patch-panels for connection to separate voice and data equipment supplied by the Tenant. 

The security system is based on a limited strategy for Silevo’s security demands, which relies on the building exterior as the primary
secure perimeter with no site security gates or controls to enter the parking or general service-warehouse loading zones. Approximately four primary card access entry points (one along North-South staff circulation corridor and one at main office
lobby), plus 2 secured doors at each of the two warehouse points, shall be provided with none-manned security access (card-swipe) entry protocol, which will rely on employee monitoring to ensure no-tailgating. A limited closed-circuit television
(CCTV) system is anticipated, to monitor parking, loading area and two staff entry doors only, located at the main reception desk or an area designated by the Tenant. Hazardous chemicals that require secure access is planned to be by
secure/controlled-monitored access to individual buildings-rooms within the Process Central Plant, where they are housed. 

  
 2 

 The following design parameters descriptions are based on detailed meetings, discussions and collaborations
between the LPCiminelli (LPC) design team, including EYP Architecture & Engineering, P.C. (EYP) and M+W Group U.S. (M+W), with CNSE. 
  

	A.	Facility Central Plant Systems 

 The Central Plant systems for the Facility include Heating
Water, Chilled Water/Cooling Towers, HVAC (Makeup & Recirculating Air), Plumbing systems, local area heating systems, MV Electrical Power Distribution and Building Controls. 

The Heating Water system consists of packaged Boilers along with a primary and secondary pumped distribution system, and packaged (vendor)
controls. The Chilled Water system consists of Chillers and Cooling Towers along with a primary and secondary pumped distribution system, and packaged (vendor) controls. The HVAC system consists of Makeup Air units and Recirculating Air units, which
provide adequate air to ventilate the facility per code requirements and to condition the building space per BOD requirements, including Cleanroom space as required. The HVAC systems are supplied with packaged (vendor) controls. The Plumbing systems
consist of a sanitary drain network, domestic water network, and furnishings and fixtures as required by code and BOD. Local heating systems consist of gas-fired unit heaters for those areas requiring supplemental heat or those areas not directly
served by an air handler. The Medium Voltage (MV) Electrical Power Distribution system accepts the power feed from the Incoming Electrical Power system, downstream of the 34.5kV substations, and distributes power via individual switchgear lineups at
4160V and 480V for Central Plant and process loads, and further distribution down to 208V for miscellaneous convenience loads and lighting systems. Building Controls consist of an industrial grade FMCS which will receive inputs from the various
vendor control systems to provide overall status and monitoring capability. 
  

	B.	Process Specific Facility Support Systems 

 The Process Specific support systems for the
Facility include Process Cooling Water, RO/DI Water, Process Vacuum, Clean Dry Air, Exhaust Systems, Wastewater Collection and Treatment Systems, Bulk Gas Systems, Specialty Gas Systems and Chemical Systems. 

The PCW System consists of heat exchangers and a pumped distribution system to supply cooling water to the process tools. The RO/DI Water
System consists of a two stage water treatment system to provide RO Water and DI Water to the process tools and to other facility users via a two separate distribution loops. The Process Vacuum system consists of a Vacuum Pump system with
distribution to process tools. The CDA system consists of air compressors, dryers and filters along with a distribution system supplying air to the process tools and to other facility users. Exhaust Systems consist of General Exhaust fans &
ductwork to ventilate the process tools and the building spaces, an Acid Exhaust System to ventilate the process tools with scrubbers to treat the exhaust prior to discharge, and two specialty Exhaust Systems (Caustic and Pyrophoric) to ventilate
hazardous vapors from the process tools. The Wastewater Collection and treatment systems consist of several general purpose and specialty waste collection systems to carry drains from the process tools and other facility users to various collection
systems. Treatment of waste streams includes HF Waste Treatment and pre-treatment of recycled rinse water for use in the RO/DI system. Other collected systems will be trucked off site or locally treated as required. Bulk Gas systems include
distribution only for Nitrogen, Oxygen, Argon and Hydrogen. Gas generation will be provided by others via a leased plant or by truck deliveries, and the distribution systems will supply the Bulk Gases to the process tools. Specialty gas systems
include both Bulk and Cabinet fed systems which supply, monitor and control the gases to the process tools NF3 will be a bulk-fed distribution systems with capacity to be supplied by others. Approximately 10 specialty gases will be supplied as per
the Tool Utility Matrix. Process Chemicals will be supplied by either a facility dispensing system or via manual feed, depending on volumes. Process Chemicals which are facility dispensed will include tank storage and blending as required, along
with controls, monitoring and distribution to the process tools. Approximately 17 chemicals will be supplied as per the Tool Utility Matrix. 

  
 3 

 EXHIBIT B-2 

INFRASTRUCTURE 
 EXHIBIT IS SUBJECT TO
MODIFICATIONS AS JOINTLY DETERMINED BY SILEVO AND FOUNDATION AS SILEVO AND FOUNDATION JOINTLY ENGAGE THE DEVELOPER TEAM TO FINALIZE BUILDING SPECIFICATIONS, LOCATION, AND SITE SPECIFICATIONS. 

The following design parameters descriptions are based on detailed meetings, discussions and collaborations between the LPCiminelli (LPC) design team,
including EYP Architecture & Engineering, P.C. (EYP) and M+W Group U.S. (M+W), with CNSE. 
  

	A.	Overall Site Improvements 

 The overall improvements to the site, related to Tenant B
(“Silevo” or “Tenant”) 1-GW Facility, are located within the boundaries of the Area 1 Parcel with limited additional site infrastructure improvements extended into parcel known as the “Railroad Area”, formerly owned by
the Norfolk Southern Railroad. Site improvements include: (1) parking for 750 staff spaces, including limited additional parking for visitors up to approximately 15 spaces; (2) main campus entry road off of South Park Avenue, with both
main parking and service access driveways off of the main campus drive; (3) warehouse loading access for approximately six (6) loading bays along the Southeast end of the facility, with an additional two loading bays at the Northwest end
to serve the incoming storage of wafer material, as well as a small drop-off and trash pick-up area located at the North end of the facility for the office/amenity requirements; (4) limited pavement and secondary access drives to support
delivery and operational requirements for chemical, specialty gas and waste removal by vehicles entering/exiting the site; (5) landscape plantings along ends of parking bays facing South Park Avenue and between the Facility and main campus
drive(s) for screening of loading docks and service areas, as well as landscape improvements along the riverfront; (6) paving/walks/plazas-patios, as necessary to provide pedestrian access between the parking areas and entry points;
(7) incoming Facility utility services for water, natural gas, sanitary sewer, primary electric, including required substation, and telecommunications, up to a point within approximately 5 feet of the Facility enclosure typically. 

 

	B.	Sub-foundation Piles Supporting Structure 

 The steel structures columns and ground level areas
are supported on pile-supported column caps and a two-way structured slab, designed to meet a uniform 250 pounds per square foot (psf) load typically. Individual equipment or other point loads are anticipated to be accommodated by the modifications
to the Tenant’s equipment vendor-suppliers equipment-systems to be supported on an appropriately designed spread-base to meet the floor load design. 

For narrative description of the remainder of the building and structural design parameters, see Items B through F in the separate Building
Design Parameters Description. 
  

	C.	Site Utility Systems 

 The Fire Water system consists of a Fire Water Booster Pump, which
maintains the Fire Loop at a mandated pressure. No Fire Water storage is included. 
 The Incoming Electrical Power system accepts the output
of the Site Switchyard which transforms the 115kV Utility feed down to 34.5kV. The 34.5kV feed is routed overhead to a set of Incoming Substations, which then feeds the Medium Voltage Electrical Power Distribution system and the individual
switchgear lineups. 
 The Emergency Power system consists of (2) Emergency Generators, which are connected to critical building loads
via Emergency Switchgear and Automatic Transfer Switches. The Emergency Generators are stand-alone units provided with outdoor enclosures and on-boards fuel storage. 

 The Acid Waste Treatment system consists of a collection network from the facility feeding into
an outdoor Waste Treatment building which provides pH Neutralization of the effluent prior to discharge to the Site Sewer system. 
 The
Silane Gas system consists of specialized protection, offload & distribution infrastructure to support a leased Bulk Silane Gas Storage Tank. The Silane Tank will be owned by an external gas provider with periodic fills as required to
support capacity. The Silane Tank shall be protected and or isolated as required by code and facilities shall be provided for offloading of Silane and for distribution to the Building. 

 

	D.	Piles, removal or other work to be performed as a result of the presence of fill or any other conditions present on the Site. 

  
 5 

 EXHIBIT C 

MANUFACTURING EQUIPMENT 
 General Equipment
Listing 
  

							
	 Category
	 	Item No.	 	 Process Flow
	 	 General Equipment Name

	Process	 	1	 	Wafer Inspection	 	WIS
	 	2	 	Cassette Exchange	 	Stack to ACI
	 	3	 	Texture	 	SDE Wet Bench
	 	4	 	Cassette Exchange	 	
	 	5	 	Preclean	 	Clean & Oxide Wet Bench
	 	6	 	CVD	 	PECVD a-Si Deposition
	 	7	 	Load/Unload Automation	 	PECVD Loader/Unloader
	 	8	 	PVD	 	TCO & Metal Deposition
	 	9	 	Load/Unload Automation	 	PVD Loader/Unloader
	 	10	 	Laminator 1	 	Pattern Lamination
	 	11	 	Load/Unload Automation	 	Laminator Loader/Unloader
	 	12	 	Exposure 1	 	Pattern Exposure
	 	13	 	Cover Sheet 1	 	Pattern Cover sheet
	 	14	 	Develop 1	 	Pattern Develop
	 	15	 	Pattern Automation	 	Conveyor for Patterning
	 	16	 	Electroplating	 	Cu Electroplating
	 	17	 	Load/Unload Automation	 	Electroplate Loader/Unloader Jig
	 	18	 	PR Strip	 	Photoresist Strip
	 	19	 	Laminator 2	 	Pattern Lamination
	 	20	 	Load/Unload Automation	 	Laminator Loader/Unloader
	 	21	 	Exposure 2	 	Pattern Exposure
	 	22	 	Develop 2	 	Pattern Develop
	 	23	 	Pattern Automation	 	Conveyor for Patterning
	 	24	 	Oven 2	 	Oven for Pattern 2
	 	25	 	Edge Isolation	 	Wet Bench
	 	26	 	Oven Box	 	Oven Box
	 	27	 	Cassette Exchange	 	Stack to ACI
		 	28	 	Testing	 	Cell Tester/Sorter
				
	Metrology	 	1	 		 	Sinton
	 	2	 		 	Angstrom
	 	3	 		 	EL Tester
	 	4	 		 	Electronic Balance
	 	5	 		 	OM
	 	6	 		 	4-Probe Tester
	 	7	 		 	Reflectometer
	 	8	 		 	SEM
	 	9	 		 	PL-P1
				
	General	 	1	 		 	Scrubber
	 	2	 		 	CVD Pump
				
	Module	 	1	 	Module Packaging	 	Turn-Key Module Assembly Line

  

 EXHIBIT D 

INTELLECTUAL PROPERTY AND JOINT PROJECTS 
  

	1.	Definitions 

 In addition to the terms defined elsewhere in this Agreement, for the
purposes of the Agreement, including this Exhibit, the following terms have the described meanings listed below. 
  

	 	a.	Foreground Non-Patent IP 

 Foreground Non-Patent IP means all know-how, trade secrets,
copyrights, rights in computer programs, documentation, and mask layout designs in physical and/or electronic form and other intellectual property (other than patents and Foreground Patent IP) developed during Projects. Foreground Non-Patent IP
shall not include the results of any research or project rejected by the Parties and undertaken by a Party or its Representatives outside the Projects, or the results of any other program undertaken by a Party or its Representatives outside the
Projects. 
  

	 	b.	Foreground Patent IP 

 Foreground Patent IP means patents and patent applications
(including, but not limited to, design, utility, utility model, provisional, continuation, continuation-in-part, divisional, reexamination, reissue or extensions) in any country or jurisdiction of either Party or its Representatives on Project
Inventions. 
  

	 	c.	FOUNDATION Personnel 

 FOUNDATION Personnel shall mean the general, administrative and
research employees and the independent contractors and consultants of FOUNDATION, CNSE, FRMC, SUNY IT, and the FOUNDATION, CNSE and SUNYIT faculty, researchers, research assistants, teaching assistants, and students who are or who are expected to be
performing activities under or in respect of the Program. For the avoidance of doubt, FOUNDATION Personnel shall not include employees or contractors of SILEVO. 
  

	 	d.	Joint Projects 

 Joint Projects means research program(s) approved by the Parties for
performance jointly by the Parties in respect of the Program pursuant to a Statement of Work. 
  

	 	e.	Program 

 Program means the various activities undertaken or conducted by or on behalf
of the Parties throughout the Term of and pursuant to the terms and conditions of this Agreement, including, without limitation, activities involving the preparation for and the execution of the Projects. 

  

	 	f.	Project Inventions 

 Project Invention(s) shall mean an invention(s) conceived and/or
first reduced to practice (within the meaning of the prevailing US Patent Laws) by an employee, contractor or consultant of a Party in the conduct of a Project(s). 
  

	 	g.	Proprietary Technical Projects 

 Proprietary Technical Project(s) shall mean research
programs performed solely for SILEVO within the Program that are not Joint Projects. 
  

	 	h.	Representatives 

 Representative(s) shall mean a Party’s agents, contractors, or
employees and employees, contractors or agents of a Party’s Affiliates and, in the case of FOUNDATION, FOUNDATION Personnel. 
  

	 	i.	US Patent Law(s) 

 US Patent Law(s) shall mean 35 U.S.C. Section 1 et seq.,
37 C.F.R. Section 1 et seq., and the case law interpreting such statutes, regulations and the rights incident thereto. 
  

	2.	Treatment of CNSE Facilities 

 The Parties recognize that, in consideration of
SILEVO’s contributions to be provided pursuant to Section IV of the Agreement, and in conjunction with SUNY’s Cooperative Use of Equipment Policy, in addition to the Manufacturing Facility, which will be leased to SILEVO by FOUNDATION
or its Affiliate, the CNSE Facilities will be made available for access and use by SILEVO for Proprietary Technical Projects in accordance with the terms of this Agreement provided that such access does not impair the commercial operation of the
Facility. Further, in recognition of each Party’s respective contributions to the Program, the CNSE Facilities used by the Parties for Joint Projects will be considered a joint use of facilities. FOUNDATION warrants that the treatment of the
CNSE Facilities as a joint use of facilities, as set forth in this Section 2 of this Exhibit, is consistent with and facilitates the ownership of intellectual property created under the Program, as set forth in Section 4 of this Exhibit.

  

	3.	Reporting of Joint Project Inventions 

 Representatives of the Parties performing
services under the Joint Projects shall promptly report in a reasonably detailed written disclosure all Joint Project Inventions to their applicable Party. Within sixty (60) days after receipt, each Party shall provide a copy of such invention
disclosure(s) received on a Joint Project Invention to the other Party. The Program Managers (or their mutually agreed designee) shall maintain a reasonably detailed written log of all Joint Project Inventions. 

 

	4.	Ownership of Project Intellectual Property 

  

	 	(a)	Foreground Patent IP shall be owned by the Party or Parties whose Representatives are inventors of the underlying Project Invention as a matter of US Patent Law. The owning Party or Parties shall retain the entire
right, title, and interest throughout the world to such Foreground Patent IP including, without limitation, the right to file (or not to file) for patents for such Project Invention(s). Any Foreground Patent IP on Project Inventions invented jointly
by the Parties’ Representatives as a matter of U.S. Patent Law shall be jointly owned by the Parties and shall be licensable by each Party without accounting to or permission from the other Party. 

  
 2 

	 	(b)	Foreground Non-Patent IP shall be owned by the Party or Parties whose Representatives developed such Foreground Non-Patent IP. The owning Party or Parties shall retain the entire right, title, and interest throughout
the world to such Foreground Non-Patent IP including, without limitation, the right to register (or not to register) such Foreground Non-Patent IP. Any Foreground Non-Patent IP developed jointly by the Parties’ Representatives shall be jointly
owned by the Parties and shall be licensable by each Party without accounting to or permission from the other such Party. 

  

	5.	Patent Filing for Project Inventions 

 The decision on filing of patents for Project
Inventions shall be made by the Party having an ownership interest in such Project Invention. In the event of a dispute, such Party shall refer the dispute in writing to the senior executives of the Parties, as described in Section X of this
Agreement, who shall discuss and meet in person, if necessary, in order to negotiate a resolution of the dispute. If the Parties together own Project Inventions, they shall equitably share the cost of obtaining and maintaining any resulting
Foreground Patent IP on such Project Inventions. In the event that a Party owning such a Project Invention elects not to seek patent protection for such Project Invention in any particular country or not to share equally in the expense thereof with
the other owning Party, the other owning Party shall have the right to seek or maintain such protection at its own expense in such country and shall have full control over the prosecution and maintenance thereof even though title to any patent
issuing therefrom shall be joint among the entities owning such Project Invention. Any election by a Party not to share equally in the expenses associated with seeking patent protection for any Project Invention shall not be construed as a
termination event under Section XI. 
  

	6.	Restriction on Confidential Information in Patent Applications 

 Neither Party may
disclose any Confidential Information of the other Party in any patent application or in the prosecution of such patent application without the written approval of the Party owning such Confidential Information, which approval shall not be
unreasonably withheld or delayed. 
  

	7.	Assistance for Patent Protection 

 Each Party, at its own expense, shall reasonably
assist the other Party in obtaining patent protection for joint Project Inventions. Such assistance shall include, without limitation, provision of invention disclosure documents which include data and examples, causing the execution of assignments
and other instruments and provision of such documents as the other Party may reasonably consider necessary or appropriate to the obtaining of patent protection. The Parties shall cooperate to facilitate compliance with the duty of disclosure
requirements for patent application filing and/or prosecution. 

  
 3 

	8.	Project Invention Disclosure Review 

 At least on an annual basis, during the Term of
this Agreement, each Party must report in writing to the other Party on the status of all Project Invention disclosures, any corresponding patent applications, and any corresponding issued patents for which it is responsible. For one (1) year
after the expiration or earlier termination of this Agreement, each Party must report in writing to the other Party the status of all Project Invention disclosures, any corresponding patent applications, and any corresponding issued patents for
which it is responsible. 
  

	9.	Activity at Other Facilities 

 Any intellectual property developed by SILEVO in any other
FOUNDATION, SUNY CNSE/SUNY IT-owned facilities outside of those provided for the Program is not part of this Agreement and shall be subject to the terms and conditions of any separate contract or agreement executed between SILEVO and FOUNDATION.

  

	10.	No Restriction on Licensing Owned Patents 

 Nothing in this Agreement shall be construed
as limiting the ability of either Party to grant non-exclusive licenses under any patents in which that Party has an ownership interest and/or otherwise has the right to grant licenses. 

 

	11.	Joint Project Costs and Personnel 

 Except as otherwise expressly agreed to in this
Agreement or the corresponding SOW, each Party shall be responsible for and shall bear (a) all of its own costs and expenses for a Joint Project and (b) all responsibility for all personnel that it uses for a Joint Project. 

 

	12.	Project Approval Process 

 The Parties shall define each new Joint Project by
implementing a signed SOW, substantially in the form of the statement of work set forth in this Exhibit, setting forth the appropriate work items for carrying out each respective Joint Project. All Projects which involve the operation of CNSE Tools,
including Manufacturing Equipment, by FOUNDATION Personnel will also require a signed SOW setting forth the appropriate work items for carrying out each respective Joint Project. Each SOW shall include a start date, a Joint Project Target End Date,
a Joint Project description, target process development objectives, milestones, the expected roles of the Parties, and the scope of work, with all dates and time periods in each SOW being targets only. The Program Managers shall be responsible for
coordinating communications and execution of actions toward achievement of the milestones. Each Party will use commercially reasonable efforts for the successful completion of milestones. The Parties may from time to time, as new SOWs are developed
within the budget, amend Exhibit D to add such SOWs as necessary. Upon written acceptance by the Parties, such additional SOWs will become part of this Agreement and attached in this Exhibit. Failure however to formally amend this Exhibit has no
bearing on the agreed Joint Project SOW becoming part of the Program and part of this Agreement. 
  

	13.	Statement of Work Form 

  
 4 

 STATEMENT OF WORK 

This Statement of Work (“SOW”), effective as of
                    , 20        (“SOW Effective Date”), is entered into by THE RESEARCH FOUNDATION
FOR THE STATE UNIVERSITY OF NEW YORK (“FOUNDATION”), a non-profit educational corporation existing under the laws of the State of New York, having an office located at 257 Fuller Road, Albany, New York 12203, on behalf of the College of
Nanoscale Science and Engineering (“CNSE”) of the State University of New York (the “SUNY”), and SILEVO, INC. (“SILEVO”), a Delaware corporation with its principal office located at 45655 Northport Loop East, Fremont,
California 94555, for a project under and pursuant to that certain AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON TRIEX MODULE TECHNOLOGY (“Agreement”) between FOUNDATION and SILEVO effective as of
September         , 2014. Capitalized terms used and not defined in this SOW have the meanings set forth in the Agreement. 

All dates and time periods in this SOW are targets only. 
  

	1.	Start Date: 

  

	2.	Joint Project Target End Date: 

  

	3.	Joint Project Description: 

  

	4.	Target Process Development Objectives: 

  

	5.	Milestones: 

  

	6.	Expected Roles of the Parties: 

  

	7.	Scope of Work: 

 IN WITNESS WHEREOF, the Parties hereto have caused this SOW to be executed and
delivered by their duly authorized representatives as of the SOW Effective Date. 
  

			
	 THE RESEARCH FOUNDATION FOR

THE STATE UNIVERSITY OF NEW YORK

			
		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	Operations Manager
	 Date:
	 	                    , 201    

  

			
	 SILEVO, INC.

		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	
	 Date:
	 	                    , 201    

  
 5 

 EXHIBIT E 

CONFIDENTIALITY 
  

	1.	Disclosure of Confidential Information 

  

	 	(a)	Each Party may disclose and receive Confidential Information (defined below) from the other Party. 

  

	 	(b)	“Confidential Information” shall mean all information that (i) is maintained in confidence by a Party (“Owning Party”), (ii) is disclosed to or obtained by the other Party in connection
with and during the Term of this Agreement, including, but not limited to, information that relates to such Owning Party’s or its Affiliates’ past, present or future research, development, manufacturing, or business activities relating to
the Essential Purposes, and (iii) is information that may be exempted from disclosure under Articles 6 and 6-A of the New York Public Officers Law. Either Party (“Disclosing Party”) may disclose its Confidential Information to the
other Party (“Receiving Party”) orally, in writing, or by other media or transfer of materials including graphic, photographic, recorded, prototype, sample, or other tangible or permanent form clearly and obviously marked
“confidential” or “proprietary”. Electronic information will be adequately marked if the container is marked and if a proprietary legend displays when the information runs on a computer system and when the information is printed
from its data file. 

  

	 	(c)	When disclosed orally, Disclosing Party shall identify the information as confidential at the time of such disclosure, with subsequent written confirmation to Receiving Party within thirty (30) days of such
disclosure indicating the date and type of information disclosed. All restrictions provided herein regarding use and/or disclosure shall apply during such thirty-day period. 

 

	2.	Protecting confidential information 

  

	 	(a)	Receiving Party will retain Disclosing Party’s Confidential Information in confidence for three (3) years from the date of disclosure. Receiving Party will not disclose, disseminate, or publish any of
Disclosing Party’s Confidential Information to any person except employees or agents of Receiving Party on a need to know basis, except as consistent with the Receiving Party’s obligations under Articles 6 and 6-A of the New York Public
Officers Law, or other applicable law, regulation or legal process. Receiving Party shall ensure that such employees or agents shall be bound by terms at least as protective as the terms of this Exhibit E. Each Party warrants that employees or
agents shall comply with the terms of this Exhibit E. Upon the termination or expiration of this Agreement, the Parties shall confer regarding the status of Confidential Information disclosed and/or created under this Agreement. 

 

	3.	Ownership 

 All right, title and interest in Disclosing Party’s Confidential
Information which is furnished to the Receiving Party shall be and remain the property of the Disclosing Party. 

  

	4.	Standard of Care 

 The Receiving Party shall be held to the same standard of care in
protecting Disclosing Party’s Confidential Information as the Receiving Party normally employs to preserve and safeguard its own Confidential Information of similar kind, but in no event less than reasonable care. 

 

	5.	Exclusions; Required Disclosure 

  

	 	(a)	Receiving Party’s obligations regarding Disclosing Party’s Confidential Information shall not apply to information (a) that was already known to Receiving Party prior to the disclosure of such information
to Receiving Party by Disclosing Party, (b) that is or becomes publicly available through no act or fault of Receiving Party, (c) that is rightfully received by Receiving Party from a third-party having no obligation of confidentiality to
Disclosing Party, or (d) that is independently developed by Receiving Party. 

  

	 	(b)	In the event FOUNDATION is required by law, regulation, or court order to disclose any of SILEVO’s Confidential Information, FOUNDATION will notify SILEVO in writing prior to making such disclosure in order to
facilitate SILEVO seeking a protective order or other appropriate remedy from the appropriate legal body. In the event SILEVO is required by law, regulation, or court order to disclose any of FOUNDATION’s Confidential Information, SILEVO will
notify FOUNDATION in writing prior to making such disclosure in order to facilitate FOUNDATION seeking a protective order or other appropriate remedy from the appropriate legal body. Notwithstanding the foregoing, a Party or its successor shall be
permitted to share the other Party’s Confidential Information as needed with its and its Affiliates’ lawyers, accountants, architects and other consultants and advisors. The Receiving Party further agrees that if the Disclosing Party is
not successful in precluding the requesting legal body from reviewing the Confidential Information, it will furnish only that portion of the Confidential Information which is legally required and will exercise all reasonable efforts to obtain
reliable assurances that confidential treatment will be accorded the Confidential Information. 

  

	6.	Protection of Plans and Specifications for CNSE Facilities 

 SILEVO agrees that all
plans, specifications and drawings for the CNSE Facilities (collectively, the “CNSE Facilities Documents”) and all rights therein (including trademarks, trade names, rights of use, copyrights and/or other proprietary rights) shall be and
remain the sole property of FOUNDATION and shall be treated as FOUNDATION’s Confidential Information (whether or not the Parties terminate or withdraw from this Agreement for any reason whatsoever); provided, however, all of the foregoing that
is uniquely required for the development or manufacturing of SILEVO proprietary Triex products shall be SILEVO’s Confidential Information and provided SILEVO shall have the right to use any CNSE Facilities Documents to the extent required to
repair and operate the Manufacturing Facility. Except as expressly provided for in this Agreement, SILEVO shall not use (or distribute) the CNSE Facilities Documents without FOUNDATION’s prior written consent. This Section shall survive
the term or termination of this Agreement. 

  
 2 

 EXHIBIT F 

SILEVO INSURANCE REQUIREMENTS 

SILEVO shall obtain the following insurance coverage and/or limits to be effective upon the earlier of Manufacturing Facility Completion or
SILEVO’s entry into the Manufacturing Facility: 
  

	 	(a)	SILEVO shall maintain (or cause to be secured and maintained) for the benefit of FOUNDATION (as an additional insured), annual commercial general public liability insurance (or a combination of commercial general
liability insurance, self-insurance and/or umbrella liability insurance) with a combined single limit per occurrence of not less than $2 Million, and an aggregate limitation of not less than $2 Million, together with umbrella coverage of $5 Million,
which insurance covers third party bodily injury and property damage. 

  

	 	(b)	Business Automobile Liability with limits of insurance of not less than $1,000,000.00 each accident. 

  

	 	(c)	Workers Compensation & Employers Liability with limits of insurance of not less than the amount required by New York State. This policy shall contain an All States Endorsement. 

 

	 	(d)	SILEVO shall purchase and maintain for the duration of this agreement Property Insurance (PI) for replacement cost of personal property/equipment of others and/or personal property that is in the care, custody and
control of SILEVO (other than the Manufacturing Equipment). This policy should provide “all-risk” coverage and shall include coverage for the perils of “testing”, “calibrating” and “mechanical breakdown.”

  

	 	(e)	SILEVO will name FOUNDATION, CNSE, FSMC, SUNY IT, SUNY and the State of New York, as Additional Insureds on the commercial general liability insurance policy. Purchase and maintenance of such insurance shall in no way
be interpreted as relieving SILEVO of any of its responsibilities or liabilities hereunder, and SILEVO may carry, at its expense, such additional insurance amounts and coverage as it deems necessary. The commercial general liability insurance for
the Additional Insureds shall be as broad as the coverage provided for the named insured party. Except due to claims caused by the negligence of the FOUNDATION, SILEVO’s commercial general liability insurance shall apply as primary and
non-contributing insurance before any insurance maintained by the Additional Insureds. SILEVO shall maintain coverage for itself and all Additional Insureds for the duration of the term of this Agreement. 

FOUNDATION shall obtain, at its sole cost, the following insurance coverage: 

FOUNDATION (or its Affiliate) shall purchase and maintain for the duration of this Agreement Property Insurance (PI) that includes coverage for
the Manufacturing Facility and Manufacturing Equipment for the replacement cost thereof, including builder’s risk insurance on the Manufacturing Facility while it is under construction. This policy should provide “all-risk” coverage
and shall include coverage for the perils of “testing”, “calibrating” and “mechanical breakdown.” 

  

 Each party hereby agrees as follows: 

 

	 	(i)	Notwithstanding anything to the contrary in the Agreement, including Sections 15.5 and 15.8, each Party and its respective insurers waives all rights against the other Party, including, with respect to SILEVO, as a
Party, and FOUNDATION, as the other Party, FSMC, SUNY, SUNY IT, CNSE, the State, as well as such entities’ officers, directors, trustees and employees, for recovery of damages to property to the extent these damages are due to a risk covered by
property insurance required to be maintained by such Party per the requirements stated above.  

  

	 	(ii)	Upon signing of this Agreement and immediately upon renewal or replacement of any and all insurance policies required hereunder, each Party shall furnish to the other certificates of insurance evidencing all coverages
required hereunder, to which copies of all additional insured endorsements and loss payee endorsements required hereunder, executed by the insurers, shall be attached. Certificates of insurance shall afford the other Party thirty
(30) days’ notice of cancellation with ten (10) days’ notice provided for non-payment of premium. 

  
 2 

 EXHIBIT G 

INVESTMENT AND JOB MILESTONES 
  

	1.	Subject to Section 2 of this Exhibit G, commencing on the date of the first anniversary of the date on which Manufacturing Facility Completion is achieved, for each Program Year, if SILEVO fails to achieve the
Investment and Job Milestones, SILEVO shall pay the Program Payment for the Program Year on or before the Milestone Payment Due Date, as specified in Schedule A below. 

Schedule A 
  

															
	 Program
Year
	 	Program Payment Due
Dates	 	Program
Payment Due	 	 	SILEVO
Cumulative
Investment
(as described in
Section 4.3 of the
Agreement)
Milestone	 	 	SILEVO
Cumulative
Job
(as described in
Section 4.4 of the
Agreement)
Milestone	 
	1	 	First Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	130,000,000	  	 	 	600	  
	2	 	Second Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	472,000,000	  	 	 	1,350	  
	3	 	Third Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	928,000,000	  	 	 	2,000	  
	4	 	Fourth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	1,478,000,000	  	 	 	2,500	  
	5	 	Fifth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	2,056,000,000	  	 	 	3,460	  
	6	 	Sixth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	2,625,000,000	  	 	 	3,460	  
	7	 	Seventh Anniversary
of the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	3,208,000,000	  	 	 	3,460	  
	8	 	Eighth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	3,793,000,000	  	 	 	3,460	  
	9	 	Ninth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	4,391,000,000	  	 	 	3,460	  
	10	 	Tenth Anniversary of
the Manufacturing
Facility Completion
Date	 	$	41.2 Million	  	 	$	5,000,000,000	  	 	 	3,460	  

	2.	If, with respect to a Program Year above in Schedule A, SILEVO satisfies the Investment Target and Manufacturing Target set forth in Schedule A on or before the applicable Program Payment Due Date for the Program Year,
then SILEVO is not required to pay the Program Payment Due for the Program Year on such Program Payment Due. 

  

	3.	If any of the following events of default occur, all Program Payments in Schedule A shall become due and payable immediately, without demand or notice: 

 

	 	1.	the failure of SILEVO to pay in full a Program Payment payable by SILEVO to FOUNDATION in accordance with Sections 1 and 2 of this Exhibit G on or before the applicable Program Payment Due Date, which payment remains
unpaid for ten (10) business days after delivery of written notice of such failure to SILEVO; 

  

	 	2.	the filing of bankruptcy proceedings involving SILEVO as a debtor (which is not dismissed within ninety (90) days of filing); 

  

	 	3.	the appointment of a receiver for SILEVO; 

  

	 	4.	the making of a general assignment for the benefit of SILEVO’s creditors; 

  

	 	5.	the termination of the Agreement due to SILEVO’s default thereunder. 

  

	4.	The terms and conditions contained in this Exhibit G shall survive the termination of the Agreement. 

  
 2 

 EXHIBIT H-1 

LEGAL DESCRIPTION OF SITE 
 Parcel
“A” (Area I) 
 ALL THAT TRACT OR PARCEL LAND, situate in the City of Buffalo, County of Erie and State of New York being part of
Lot 16, Township 10, Range 8 of the Ogden Gore Tract and Lots 57, 58, and 60, Township 10, Range 8 of the Buffalo Creek Indian Reservation, bounded and described as follows: 

BEGINNING at a point in the southwest bounds of South Park Avenue (also known as Abbott Road), being 66 feet wide, at a distance of 124.53 feet northwesterly
from the northwest bounds of New Abby Street, measured along said southwest bounds; 
 Thence southwesterly, at an angle of 57 degrees 09’ 00”
measured in the westerly quadrant from the said southwest bounds, a distance of 160.56 feet to the southwest corner of said Republic Steel Corporation lands, being a point of curvature in the former north line of lands owned by the Delaware,
Lackawanna and Western Railway Company; 
 Thence westerly, curving to the right along the arc of a circular curve with a radius of 987.81 feet, a distance
of 275.12 feet to a point; 
 Thence southerly, radially to the last described course and along the easterly line of lands conveyed to Republic Steel
Corporation by deed recorded in Liber 8777 at page 519, a distance of 99.0 feet to the southeast corner of the last described lands; 
 Thence
southwesterly, at an interior angle of 111 degrees 23’ 58” and along the south line of the last described lands, a distance of 385.72 feet to angle point in said south line; 

Thence southwesterly, at an exterior angle of 174 degrees 54’ 45” and continuing along the south line of the last described lands, a distance of
520.38 feet to a point; 
 Thence southwesterly, at an exterior angle of 156 degrees 42’ 46”, a distance of 40.00 feet to a point in the north
line of lands formerly owned by the New York, Lackawanna and Western Railway Company; 
 Thence westerly, curving to the right along the arc of a circular
curve with a radius of 4,911.15 feet, being along the north line of the last described railway, a distance of 78.65 feet to the northeast corner of lands conveyed to Republic Steel Corporation by deed recorded in Liber 7622 at page 649; 

Thence southerly, along the east line of the last described lands, a distance of 6.00 feet to the southeast corner of said last described lands; 

Thence westerly and northerly along the south and west lines of the last described parcel, the following courses and distances: 

Westerly, curving to the right along the arc of a circular curve with a radius of 4,767.15 feet, a distance of 285.00 feet to a point of tangency; 

 Westerly, tangent to the last described curve, a distance of 172.06 feet to a point; 

Southerly, at an exterior angle of 108 degrees 44’ 02”, a distance of 39.90 feet to a point; 

Westerly, at an interior angle of 105 degrees 24’ 00”, a distance of 745.51 feet to a point; 

Westerly, at an interior angle of 175 degrees 27’ 34”, a distance of 171.82 feet to a point of curvature; 

Westerly, curving to the right along the arc of a circular curve with a radius of 625.50 feet, a distance of 134.18 feet to a point of compound curvature;

 Westerly, curving to the right along the arc of a circular curve with a radius of 445.85 feet, a distance of 213.99 feet to point of tangency; 

Northwesterly, tangent to the last described curve, a distance of 23.46 feet to a point of curvature; 

Northwesterly, curving to the right along the arc of a circular curve with a radius of 424.68 feet, a distance of 192.00 feet to a point of compound
curvature; 
 Northwesterly, curving to the right along the arc of a circular curve with a radius of 293.82 feet, a distance of 74.16 feet to a point in the
east bounds of the South Buffalo Railway; 
 Thence northerly, along the east bounds of the South Buffalo Railway, a distance of 88.52 feet to a point; 

Thence northerly, at an exterior angle of 179 degrees 10’ 28” and continuing along the east bounds of the last mentioned railway, a distance of
566.34 feet to a point; 
 Thence northerly, at an interior angle of 167 degrees 44’ 11” and continuing along the east bounds of the last
mentioned railway, a distance of 107.48 feet to the intersection of said east bounds with the south edge of water of the Buffalo River; 
 Thence easterly
and northerly, along the south edge of water of the Buffalo River a distance of 3,879.99 feet to its intersection with the southwest bounds of South Park Avenue; 

Thence southeasterly, along the southwest bounds of South Park Avenue, a distance of 1,412.77 feet to an angle point in said southwest bounds; 

Thence southeasterly, continuing along the southwest bounds of South Park Avenue, at an exterior angle of 161 degrees 28’ 32” a distance of 953.66
feet to the point or place of beginning. 

  
 4 

 EXHIBIT H-2 

SITE PLAN SHOWING LOCATION OF SITE 

EXHIBIT IS SUBJECT TO MODIFICATIONS AS JOINTLY DETERMINED BY SILEVO AND FOUNDATION AS SILEVO AND FOUNDATION JOINTLY ENGAGE THE DEVELOPER TEAM TO FINALIZE
BUILDING SPECIFICATIONS, LOCATION, AND SITE SPECIFICATIONS. 
  
 

 

 EXHIBIT I 

CONSTRUCTION MILESTONES 
 EXHIBIT IS
SUBJECT TO MODIFICATIONS AS JOINTLY DETERMINED BY SILEVO AND FOUNDATION AS SILEVO AND FOUNDATION JOINTLY ENGAGE THE DEVELOPER TEAM TO FINALIZE BUILDING SPECIFICATIONS, LOCATION, AND SITE SPECIFICATIONS.Exhibit 10.2 10Q 2014 Q3

EXHIBIT 10.2

Amended and Restated Change in Control Agreement
AGREEMENT made as of this __________ day of _________________ by and among Washington Trust Bancorp, Inc., a Rhode Island corporation with its principal place of business in Westerly, Rhode Island (the “Corporation”), The Washington Trust Company of Westerly, a Rhode Island banking corporation with its principal place of business in Westerly, Rhode Island (the “Bank”) and _______________ (the “Executive”), an individual presently employed as an executive of the Bank.  This Agreement supersedes and fully replaces any previous executive severance agreement. 
1.Purpose.  The Corporation considers it essential to the best interests of its stockholders to foster the continuous employment of key management personnel employed by the Bank.  The Board of Directors of the Corporation (the “Board”) recognizes, however, that, as is the case with many publicly held corporations, the possibility of a Change in Control (as defined in Section 2 hereof) exists and that such possibility, and the uncertainty and questions which it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Corporation and its stockholders.  Therefore, the Board has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Corporation and the Bank’s management, including the Executive, to their assigned duties without distraction in the face of potentially disturbing circumstances arising from the possibility of a Change in Control.  Nothing in this Agreement shall be construed as creating an express or implied contract of employment and, except as otherwise agreed in writing between the Executive and the Corporation and/or the Bank, the Executive shall not have any right to be retained in the employ of the Corporation and/or the Bank.

2.Change in Control.  For purposes of this Agreement, a “Change in Control” shall mean the occurrence of any one of the following events:
(a)Consummation by the Corporation of (i) a reorganization, merger or consolidation, in each case, with respect to which all or substantially all of the individuals and entities who were the beneficial owners of the then outstanding shares of common stock of the Corporation (the “Outstanding Corporation Common Stock”) immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or consolidation, beneficially own, directly or indirectly, more than 40% of the then outstanding shares of common stock of the corporation resulting from such a reorganization, merger or consolidation; (ii) a reorganization, merger or consolidation, in each case, (A) with respect to which all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Corporation Common Stock immediately prior to such reorganization, merger or consolidation, following such reorganization, merger or consolidation, beneficially own, directly or indirectly, more than 40% but less than 50% of the then outstanding shares of common stock of the corporation resulting from such a reorganization, merger or consolidation, (B) at least a majority of the directors then constituting the Incumbent Board do not approve the transaction and do not designate the transaction as not constituting a Change in Control, and (C) following the transaction members of the then Incumbent Board do not continue to comprise at least a majority of the Board; or (iii) the sale or other disposition of all or substantially all of the assets of the Corporation, excluding a sale or other disposition of assets to a subsidiary of the Corporation; or
(b)Consummation by the Bank of (i) a reorganization, merger or consolidation, in each case, with respect to which, following such reorganization, merger or consolidation, the Corporation does not beneficially own, directly or indirectly, more than 50% of the then outstanding shares of common stock of the corporation or bank resulting from such a reorganization, merger or consolidation or (ii) the sale or other disposition of all or substantially all of the assets of the Bank, excluding a sale or other disposition of assets to the Corporation or a subsidiary of the Corporation.

For purposes of paragraph (a) above, the term “Incumbent Board” shall mean the individuals who, as of the date of this Agreement, constitute the Board, provided that any individual becoming a director subsequent to the date of this Agreement whose election, or nomination for election by the Corporation’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office is in connection with either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Securities Exchange Act of 1934, as amended) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board.

3.Terminating Event.  A “Terminating Event” shall mean any of the events provided in this Section 3 occurring:
(a)within 12 months following a Change in Control, termination by the Corporation and/or the Bank of the employment of the Executive with the Corporation and/or the Bank for any reason other than for Cause or the death or disability (as determined under the Corporation’s and/or the Bank’s then existing long-term disability coverage) of the Executive.  “Cause” shall mean, and shall be limited to, the occurrence of any one or more of the following events: 
(i)a willful act of dishonesty by the Executive with respect to any material matter involving the Corporation and/or the Bank; or
(ii)the commission by or indictment of the Executive for (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud (“indictment,” for these purposes, means an indictment, probable cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made); 
(iii)the gross or willful failure by the Executive (other than any such failure after the Executive gives notice of termination for Good Reason) to substantially perform the Executive’s duties with the Corporation and/or the Bank and the continuation of such failure for a period of 30 days after delivery by the Corporation and/or the Bank to the Executive of written notice specifying the scope and nature of such failure and their intention to terminate the Executive for Cause.

A Terminating Event shall not be deemed to have occurred pursuant to this Section 3(a) solely as a result of the Executive being an employee of any direct or indirect successor to the business or assets of the Corporation and/or the Bank, rather than continuing as an employee of the Corporation and/or the Bank following a Change in Control.  In any proceeding, judicial or otherwise, the Corporation and/or the Bank shall have the burden of proving by clear and convincing evidence that the termination of employment was for “Cause.”  For purposes of clauses (i) and (iii) of this Section 3(a), no act, or failure to act, on the Executive’s part shall be deemed “willful” unless done, or omitted to be done, by the Executive without reasonable belief that the Executive’s act, or failure to act, was in the best interest of the Corporation and/or the Bank.
(b)Within 12 months following a Change in Control, termination by the Executive of the Executive’s employment with the Corporation and/or the Bank for Good Reason.  “Good Reason” shall mean the Executive has complied with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events:
(i)a substantial adverse change, not consented to by the Executive,  in the nature or scope of the Executive’s responsibilities, authorities, powers, position, functions, or duties from the responsibilities, authorities, powers, position, functions, or duties exercised by the Executive immediately prior to the Change in Control; or
(ii)a material reduction in the Executive’s annual base salary as in effect on the date hereof or as the same may be increased from time to time except for across-the-board salary reductions similarly affecting all or substantially all management employees; or
(iii)the relocation of the Corporation’s and/or the Bank’s offices at which the Executive is principally employed immediately prior to the date of a Change in Control to a location more than 100 miles from such offices, or the requirement by the Corporation and/or the Bank for the Executive to be based anywhere other than the Corporation’s and/or the Bank’s offices at such location, except for required travel on the Corporation’s and/or the Bank’s business to an extent substantially consistent with the Executive’s business travel obligations immediately prior to the Change in Control; or
(iv)the failure by the Corporation and/or the Bank to obtain an effective agreement from any successor to assume and agree to perform this Agreement, as required by Section 16.

“Good Reason Process” shall mean that (i) the Executive reasonably determines in good faith that a “Good Reason” condition has occurred; (ii) the Executive notifies the Corporation and/or the Bank in writing of the first occurrence of the Good Reason condition within 60 days of the first occurrence of such condition; (iii) the Executive cooperates in good faith with the Corporation’s and/or the Bank’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) the Executive terminates his employment within 60 days after the end of the Cure Period.  If the Corporation and/or the Bank cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.
(c)During the period of time after the date that the Corporation and/or the Bank enters into a definitive agreement (a “Definitive Agreement”) to consummate a transaction substantially similar to a transaction described in Section 2(a) or 2(b) hereof, and before the consummation of such transaction, termination by the Corporation and/or the Bank of the employment of the Executive with the Corporation and/or the Bank for any reason other than for 

Cause or the death or disability (as determined under the Corporation’s and/or the Bank’s then existing long-term disability coverage) of the Executive, provided, however, that such termination of the Executive’s employment shall only be considered a Terminating Event if and when the transaction contemplated by the Definitive Agreement is consummated and a Change in Control has occurred.

4.Special Termination Payments.  In the event a Terminating Event occurs, provided that the Executive has executed, returned to the Corporation and has not revoked a general release of claims in a form satisfactory to the Corporation and the Bank, no later than thirty (30) days after the Date of Termination, provided that if a Terminating Event occurs pursuant to Section 3(a), no later than thirty (30) days after the Change in Control,
(a)the Corporation and/or the Bank shall pay to the Executive an amount equal to the sum of the following:
(i)[Two (2)] times the amount of the then current annual base salary of the Executive, determined prior to any reductions for pre-tax contributions to a cash or deferred arrangement, a cafeteria plan, or a deferred compensation plan; and
(ii)[Two (2)] times the Executive’s average bonus paid in the three years prior to the Change in Control.
The foregoing amount shall be paid in one lump sum payment thirty (30) days after the Date of Termination provided that if a Terminating Event occurs pursuant to Section 3(c), the lump sum shall be paid thirty (30) days after the Change in Control; and
(b)the Corporation and/or the Bank shall continue to provide health and dental insurance to the Executive, on the same terms and conditions as though the Executive had remained an active employee, for twenty-four (24) months after the Terminating Event;
(c)the Corporation and/or the Bank shall pay to the Executive all reasonable legal and arbitration fees and expenses incurred by the Executive in obtaining or enforcing any right or benefit provided by this Agreement, except in cases involving frivolous or bad faith litigation initiated by the Executive.  Such reimbursements shall be made within sixty (60) days after the receipt of invoices, which invoices shall be submitted by the Executive within thirty (30) days of receipt.

5.Additional Limitation.
(a)Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Corporation and/or the Bank to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Internal Revenue Code of 1986, as amended (the ‘Code’) and the applicable regulations thereunder (the ‘Aggregate Payments’), would be subject to the excise tax imposed by Section 4999 of the Code (the ‘Excise Tax’), the Aggregate Payments shall be reduced to the minimum extent necessary so that no portion of the Aggregate Payments is subject to the Excise Tax but only if (A) the net amount of the Aggregate Payments, as so reduced (and after subtracting the net amount of federal, state, local and employment taxes on such reduced Aggregate Payments) is greater than or equal to (B) the Aggregate Payments without such reduction (and after subtracting the net amount of federal, state, local and employment taxes on such Aggregate Payments and the amount of Excise Tax to which the Executive would be subject in respect of such unreduced Aggregate Payments).  Any reduction in the Aggregate Payments shall be made in the following order:  (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits.  To the extent any payment is to be made over time (e.g., in installments, etc.), then the payments shall be reduced in reverse chronological order.
(b)The determination as to which of the alternative provisions of Section 5(a) above shall apply to the Executive shall be made by a nationally recognized accounting firm selected by the Corporation and/or the Bank (the ‘Accounting Firm’), which shall provide detailed supporting calculations to the Corporation and/or the Bank and to the Executive within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Corporation and/or the Bank or by the Executive.  For purposes of determining which of the alternative provisions of Section 5(a) above shall apply, the Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in the state and locality of the Executive’s residence on the Date of Termination, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes.  Any determination by the Accounting Firm shall be binding upon the Corporation and the Bank and the Executive.

6.Term.  This Agreement shall take effect on the date first set forth above and shall terminate upon the earliest of (a) the termination by the Corporation and/or the Bank of the employment of the Executive for Cause; (b) the resignation or 

termination of the Executive for any reason prior to a Change in Control; or (c) the date which is 12 months and 1 day after a Change in Control.

7.Withholding.  All payments made by the Corporation and/or the Bank under this Agreement shall be net of any tax or other amounts required to be withheld by the Corporation and/or the Bank under applicable law.

8.Notice and Date of Termination; Disputes; Etc.
(a)Notice of Termination.  After a Change in Control and during the term of this Agreement, any purported termination of the Executive’s employment (other than by reason of death) shall be communicated by written Notice of Termination from one party hereto to the other party hereto in accordance with this Section 8.  For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and the Date of Termination.  [Further, a Notice of Termination for Cause is required to include a copy of a resolution duly adopted by the affirmative vote of not less than two-thirds (2/3) of the entire membership of the Board at a meeting of the Board (after reasonable notice to the Executive and an opportunity for the Executive, accompanied by the Executive’s counsel, to be heard before the Board) finding that, in the good faith opinion of the Board, the termination met the criteria for Cause set forth in Section 3(a) hereof.] [Only for top two executives.]
(b)Date of Termination.  “Date of Termination,” with respect to any purported termination of the Executive’s employment after a Change in Control and during the term of this Agreement, shall mean the date specified in the Notice of Termination.  In the case of a termination by the Corporation and/or the Bank other than a termination for Cause (which may be effective immediately), the Date of Termination shall not be less than 30 days after the Notice of Termination is given.  In the case of a termination by the Executive, the Date of Termination shall not be less than 15 days from the date such Notice of Termination is given.  Notwithstanding Section 3(a) of this Agreement, in the event that the Executive gives a Notice of Termination to the Corporation and/or the Bank, the Corporation and/or the Bank may unilaterally accelerate the Date of Termination and such acceleration shall not result in a second Terminating Event for purposes of Section 3(a) of this Agreement.  
(c)No Mitigation.  The Corporation and/or the Bank agrees that, if the Executive’s employment by the Corporation and/or the Bank is terminated during the term of this Agreement, the Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable to the Executive by the Corporation and/or the Bank pursuant to Sections 4 and 5 hereof.  Further, the amount of any payment provided for in this Agreement shall not be reduced by any compensation earned by the Executive as the result of employment by another employer, by retirement benefits, by offset against any amount claimed to be owed by the Executive to the Corporation and/or the Bank, or otherwise.
(d)Settlement and Arbitration of Disputes.  Any controversy or claim arising out of or relating to this Agreement or the breach thereof shall be settled exclusively by arbitration in accordance with the laws of the State of Rhode Island by three arbitrators, one of whom shall be appointed by the Corporation and/or the Bank, one by the Executive, and the third by the first two arbitrators.  If the first two arbitrators cannot agree on the appointment of a third arbitrator, then the third arbitrator shall be appointed by the American Arbitration Association in Boston, Massachusetts.  Such arbitration shall be conducted in Rhode Island in accordance with the rules of the American Arbitration Association for commercial arbitrations, except with respect to the selection of arbitrators, which shall be as provided in this Section 8(d).  Judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. 

9.Assignment; Prior Agreements.  Neither the Corporation, the Bank, nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of the other party, and without such consent any attempted transfer shall be null and void and of no effect.  This Agreement shall inure to the benefit of and be binding upon the Corporation and the Bank and the Executive, as well as their respective successors, executors, administrators, heirs and permitted assigns.  In the event of the Executive’s death after a Terminating Event but prior to the completion by the Corporation and/or the Bank of all payments due him under Sections 4 and 5 of this Agreement, the Corporation and/or the Bank shall continue such payments to the Executive’s beneficiary designated in writing to the Corporation and/or the Bank prior to his death (or to his estate, if the Executive fails to make such designation).

10.Enforceability.  If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

11.Waiver.  No waiver of any provision hereof shall be effective unless made in writing and signed by the Executive and such officer as may be specifically designated by the Board.  The failure of any party to require the performance 

of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

12.Notices.  Any notices, requests, demands, and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to the Executive at the last address the Executive has filed in writing with the Corporation and/or the Bank, or to the Corporation and/or the Bank at its main offices, attention of the Board of Directors, with a copy to the Secretary of the Corporation and/or the Bank, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of a change of address shall be effective only upon receipt.

13.Effect on Other Plans.  An election by the Executive to resign after a Change in Control under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for purposes of interpreting the provisions of any of the Corporation’s and/or the Bank’s benefit plans, programs or policies.  Nothing in this Agreement shall be construed to limit the rights of the Executive under the Corporation’s and/or the Bank’s benefit plans, programs or policies.

14.Amendment.  This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative of the Corporation and/or the Bank.

15.Governing Law.  This contract shall be construed under and be governed in all respects by the laws of the State of Rhode Island.

16.Obligations of Successors.  The Corporation and/or the Bank shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Corporation and/or the Bank to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation and/or the Bank would be required to perform if no such succession had taken place.

17.Section 409A.  Notwithstanding anything to the contrary in the foregoing, if at the time of the Executive’s separation from service within the meaning of Section 409A of the Code, the Executive is considered a ‘specified employee’ within the meaning of Section 409A(a)(2)(B)(i) of the Code, and if any payment that the Executive becomes entitled to under this Agreement would be considered deferred compensation subject to interest, penalties and additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, then no such payment shall be payable prior to the date that is the earlier of (i) six months and one day after the Executive’s separation from service, or (ii) the Executive’s death.  Any such deferred payment shall earn simple interest calculated at the short-term applicable federal rate in effect on the Date of Termination.  On or before the Executive’s Date of Termination, either the Corporation or the Bank shall make an irrevocable contribution to a rabbi trust with an independent bank trustee in an amount equal to the amount of such deferred payment plus interest.

IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument by the Corporation and the Bank by their duly authorized officers and by the Executive, as of the date first above written.

WASHINGTON TRUST BANCORP, INC.
By:                            
Joseph J. MarcAurele
Chairman and Chief Executive Officer
THE WASHINGTON TRUST COMPANY OF WESTERLY
By:                            
       Joseph J. MarcAurele
Chairman and Chief Executive Officer

                        
Executive

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]